AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
142.7|149.2|145.9|7914|All ICCC Groups Combined|54370170|0-14|All Races|Male and Female|1999|||
44.2|47.9|46.0|2499|I Leukemias, myeloproliferative & myelodysplastic diseases|54370170|0-14|All Races|Male and Female|1999|||
34.6|37.8|36.2|1967|I(a) Lymphoid leukemias|54370170|0-14|All Races|Male and Female|1999|||
7.0|8.5|7.7|416|I(b) Acute myeloid leukemias|54370170|0-14|All Races|Male and Female|1999|||
0.4|0.9|0.6|33|I(c) Chronic myeloproliferative diseases|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|54370170|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|73|I(e) Unspecified and other specified leukemias|54370170|0-14|All Races|Male and Female|1999|||
14.4|16.5|15.4|835|II Lymphomas and reticuloendothelial neoplasms|54370170|0-14|All Races|Male and Female|1999|||
4.9|6.1|5.5|297|II(a) Hodgkin lymphomas|54370170|0-14|All Races|Male and Female|1999|||
5.4|6.7|6.1|329|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|54370170|0-14|All Races|Male and Female|1999|||
2.1|3.0|2.5|136|II(c) Burkitt lymphoma|54370170|0-14|All Races|Male and Female|1999|||
0.7|1.3|1.0|52|II(d) Miscellaneous lymphoreticular neoplasms|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|21|II(e) Unspecified lymphomas|54370170|0-14|All Races|Male and Female|1999|||
29.7|32.7|31.2|1696|III CNS and misc intracranial and intraspinal neoplasms|54370170|0-14|All Races|Male and Female|1999|||
2.4|3.3|2.8|154|III(a) Ependymomas and choroid plexus tumor|54370170|0-14|All Races|Male and Female|1999|||
13.0|15.0|14.0|759|III(b) Astrocytomas|54370170|0-14|All Races|Male and Female|1999|||
7.2|8.7|8.0|433|III(c) Intracranial and intraspinal embryonal tumors|54370170|0-14|All Races|Male and Female|1999|||
4.6|5.8|5.2|284|III(d) Other gliomas|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|III(e) Other specified intracranial & intraspinal neoplasms|54370170|0-14|All Races|Male and Female|1999|||
0.5|1.0|0.7|38|III(f) Unspecified intracranial and intraspinal neoplasms|54370170|0-14|All Races|Male and Female|1999|||
9.7|11.4|10.5|567|IV Neuroblastoma and other peripheral nervous cell tumors|54370170|0-14|All Races|Male and Female|1999|||
9.5|11.3|10.4|559|IV(a) Neuroblastoma and ganglioneuroblastoma|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|54370170|0-14|All Races|Male and Female|1999|||
8.6|10.3|9.4|512|IX Soft tissue and other extraosseous sarcomas|54370170|0-14|All Races|Male and Female|1999|||
4.3|5.5|4.9|265|IX(a) Rhabdomyosarcomas|54370170|0-14|All Races|Male and Female|1999|||
0.7|1.3|1.0|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|54370170|0-14|All Races|Male and Female|1999|||
2.2|3.1|2.6|143|IX(d) Other specified soft tissue sarcomas|54370170|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|50|IX(e) Unspecified soft tissue sarcomas|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|Not classified by ICCC|54370170|0-14|All Races|Male and Female|1999|||
3.8|4.9|4.3|231|V Retinoblastoma|54370170|0-14|All Races|Male and Female|1999|||
7.3|8.9|8.1|437|VI Renal tumors|54370170|0-14|All Races|Male and Female|1999|||
6.9|8.4|7.6|412|VI(a) Nephroblastoma and other nonepithelial renal tumors|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.6|0.4|22|VI(b) Renal carcinomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|54370170|0-14|All Races|Male and Female|1999|||
1.7|2.5|2.1|114|VII Hepatic tumors|54370170|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|92|VII(a) Hepatoblastoma|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.6|0.4|22|VII(b) Hepatic carcinomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|54370170|0-14|All Races|Male and Female|1999|||
6.5|8.0|7.2|391|VIII Malignant bone tumors|54370170|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|230|VIII(a) Osteosarcomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|54370170|0-14|All Races|Male and Female|1999|||
1.9|2.8|2.3|127|VIII(c) Ewing tumor and related sarcomas of bone|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|54370170|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|270|X Germ cell, trophoblastic tumors & neoplasms of gonads|54370170|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.3|73|X(a) Intracranial & intraspinal germ cell tumors|54370170|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|73|X(b) Malignant extracranial & extragonadal germ cell tumors|54370170|0-14|All Races|Male and Female|1999|||
1.7|2.5|2.1|112|X(c) Malignant gonadal germ cell tumors|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|54370170|0-14|All Races|Male and Female|1999|||
5.2|6.5|5.9|317|XI Other malignant epithelial neoplasms and malignant melanomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|54370170|0-14|All Races|Male and Female|1999|||
1.5|2.3|1.9|101|XI(b) Thyroid carcinomas|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|21|XI(c) Nasopharyngeal carcinomas|54370170|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.8|95|XI(d) Malignant melanomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|54370170|0-14|All Races|Male and Female|1999|||
1.3|1.9|1.6|85|XI(f) Other and unspecified carcinomas|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|XII Other and unspecified malignant neoplasms|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|54370170|0-14|All Races|Male and Female|1999|||
145.4|151.9|148.6|8106|All ICCC Groups Combined|54659806|0-14|All Races|Male and Female|2000|||
44.2|47.9|46.0|2506|I Leukemias, myeloproliferative & myelodysplastic diseases|54659806|0-14|All Races|Male and Female|2000|||
35.6|38.9|37.2|2026|I(a) Lymphoid leukemias|54659806|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|360|I(b) Acute myeloid leukemias|54659806|0-14|All Races|Male and Female|2000|||
0.6|1.0|0.8|42|I(c) Chronic myeloproliferative diseases|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|54659806|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|69|I(e) Unspecified and other specified leukemias|54659806|0-14|All Races|Male and Female|2000|||
15.4|17.6|16.5|904|II Lymphomas and reticuloendothelial neoplasms|54659806|0-14|All Races|Male and Female|2000|||
5.3|6.6|5.9|325|II(a) Hodgkin lymphomas|54659806|0-14|All Races|Male and Female|2000|||
5.3|6.6|5.9|323|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|54659806|0-14|All Races|Male and Female|2000|||
2.3|3.2|2.7|150|II(c) Burkitt lymphoma|54659806|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|70|II(d) Miscellaneous lymphoreticular neoplasms|54659806|0-14|All Races|Male and Female|2000|||
0.5|0.9|0.7|36|II(e) Unspecified lymphomas|54659806|0-14|All Races|Male and Female|2000|||
31.1|34.1|32.6|1780|III CNS and misc intracranial and intraspinal neoplasms|54659806|0-14|All Races|Male and Female|2000|||
2.3|3.2|2.7|148|III(a) Ependymomas and choroid plexus tumor|54659806|0-14|All Races|Male and Female|2000|||
15.6|17.8|16.7|912|III(b) Astrocytomas|54659806|0-14|All Races|Male and Female|2000|||
6.8|8.3|7.5|412|III(c) Intracranial and intraspinal embryonal tumors|54659806|0-14|All Races|Male and Female|2000|||
4.0|5.1|4.5|247|III(d) Other gliomas|54659806|0-14|All Races|Male and Female|2000|||
0.3|0.7|0.5|25|III(e) Other specified intracranial & intraspinal neoplasms|54659806|0-14|All Races|Male and Female|2000|||
0.5|0.9|0.7|36|III(f) Unspecified intracranial and intraspinal neoplasms|54659806|0-14|All Races|Male and Female|2000|||
9.1|10.8|10.0|540|IV Neuroblastoma and other peripheral nervous cell tumors|54659806|0-14|All Races|Male and Female|2000|||
9.0|10.7|9.8|533|IV(a) Neuroblastoma and ganglioneuroblastoma|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|54659806|0-14|All Races|Male and Female|2000|||
9.6|11.3|10.4|568|IX Soft tissue and other extraosseous sarcomas|54659806|0-14|All Races|Male and Female|2000|||
4.7|5.9|5.3|287|IX(a) Rhabdomyosarcomas|54659806|0-14|All Races|Male and Female|2000|||
0.7|1.2|1.0|52|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|54659806|0-14|All Races|Male and Female|2000|||
2.7|3.6|3.1|170|IX(d) Other specified soft tissue sarcomas|54659806|0-14|All Races|Male and Female|2000|||
0.8|1.4|1.1|58|IX(e) Unspecified soft tissue sarcomas|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|54659806|0-14|All Races|Male and Female|2000|||
3.8|4.9|4.3|235|V Retinoblastoma|54659806|0-14|All Races|Male and Female|2000|||
8.0|9.6|8.7|474|VI Renal tumors|54659806|0-14|All Races|Male and Female|2000|||
7.6|9.2|8.4|454|VI(a) Nephroblastoma and other nonepithelial renal tumors|54659806|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|54659806|0-14|All Races|Male and Female|2000|||
1.9|2.7|2.2|121|VII Hepatic tumors|54659806|0-14|All Races|Male and Female|2000|||
1.6|2.4|2.0|108|VII(a) Hepatoblastoma|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|54659806|0-14|All Races|Male and Female|2000|||
6.0|7.3|6.6|364|VIII Malignant bone tumors|54659806|0-14|All Races|Male and Female|2000|||
3.2|4.2|3.7|202|VIII(a) Osteosarcomas|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|54659806|0-14|All Races|Male and Female|2000|||
2.2|3.1|2.6|145|VIII(c) Ewing tumor and related sarcomas of bone|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|54659806|0-14|All Races|Male and Female|2000|||
4.3|5.4|4.8|264|X Germ cell, trophoblastic tumors & neoplasms of gonads|54659806|0-14|All Races|Male and Female|2000|||
1.2|1.8|1.5|80|X(a) Intracranial & intraspinal germ cell tumors|54659806|0-14|All Races|Male and Female|2000|||
0.8|1.4|1.1|59|X(b) Malignant extracranial & extragonadal germ cell tumors|54659806|0-14|All Races|Male and Female|2000|||
1.7|2.5|2.1|114|X(c) Malignant gonadal germ cell tumors|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|54659806|0-14|All Races|Male and Female|2000|||
5.0|6.2|5.6|305|XI Other malignant epithelial neoplasms and malignant melanomas|54659806|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|16|XI(a) Adrenocortical carcinomas|54659806|0-14|All Races|Male and Female|2000|||
1.5|2.2|1.8|101|XI(b) Thyroid carcinomas|54659806|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|54659806|0-14|All Races|Male and Female|2000|||
1.3|2.0|1.6|89|XI(d) Malignant melanomas|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|54659806|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|78|XI(f) Other and unspecified carcinomas|54659806|0-14|All Races|Male and Female|2000|||
0.4|0.9|0.6|33|XII Other and unspecified malignant neoplasms|54659806|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|54659806|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|20|XII(b) Other unspecified malignant tumors|54659806|0-14|All Races|Male and Female|2000|||
152.0|158.5|155.2|8894|All ICCC Groups Combined|57293473|0-14|All Races|Male and Female|2001|||
48.7|52.4|50.5|2882|I Leukemias, myeloproliferative & myelodysplastic diseases|57293473|0-14|All Races|Male and Female|2001|||
37.2|40.4|38.8|2208|I(a) Lymphoid leukemias|57293473|0-14|All Races|Male and Female|2001|||
6.7|8.1|7.4|423|I(b) Acute myeloid leukemias|57293473|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|93|I(c) Chronic myeloproliferative diseases|57293473|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|94|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|57293473|0-14|All Races|Male and Female|2001|||
0.9|1.4|1.1|64|I(e) Unspecified and other specified leukemias|57293473|0-14|All Races|Male and Female|2001|||
15.0|17.1|16.0|922|II Lymphomas and reticuloendothelial neoplasms|57293473|0-14|All Races|Male and Female|2001|||
5.3|6.6|5.9|341|II(a) Hodgkin lymphomas|57293473|0-14|All Races|Male and Female|2001|||
5.9|7.2|6.5|376|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|57293473|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.2|128|II(c) Burkitt lymphoma|57293473|0-14|All Races|Male and Female|2001|||
0.7|1.3|1.0|57|II(d) Miscellaneous lymphoreticular neoplasms|57293473|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|II(e) Unspecified lymphomas|57293473|0-14|All Races|Male and Female|2001|||
30.8|33.8|32.3|1845|III CNS and misc intracranial and intraspinal neoplasms|57293473|0-14|All Races|Male and Female|2001|||
2.3|3.2|2.8|158|III(a) Ependymomas and choroid plexus tumor|57293473|0-14|All Races|Male and Female|2001|||
14.9|17.0|15.9|910|III(b) Astrocytomas|57293473|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|415|III(c) Intracranial and intraspinal embryonal tumors|57293473|0-14|All Races|Male and Female|2001|||
4.7|5.9|5.3|304|III(d) Other gliomas|57293473|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.6|37|III(e) Other specified intracranial & intraspinal neoplasms|57293473|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|21|III(f) Unspecified intracranial and intraspinal neoplasms|57293473|0-14|All Races|Male and Female|2001|||
10.8|12.6|11.6|670|IV Neuroblastoma and other peripheral nervous cell tumors|57293473|0-14|All Races|Male and Female|2001|||
10.7|12.5|11.5|664|IV(a) Neuroblastoma and ganglioneuroblastoma|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|57293473|0-14|All Races|Male and Female|2001|||
9.5|11.2|10.3|592|IX Soft tissue and other extraosseous sarcomas|57293473|0-14|All Races|Male and Female|2001|||
4.5|5.7|5.1|290|IX(a) Rhabdomyosarcomas|57293473|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|57293473|0-14|All Races|Male and Female|2001|||
2.6|3.5|3.0|172|IX(d) Other specified soft tissue sarcomas|57293473|0-14|All Races|Male and Female|2001|||
0.7|1.3|1.0|57|IX(e) Unspecified soft tissue sarcomas|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|Not classified by ICCC|57293473|0-14|All Races|Male and Female|2001|||
3.8|4.9|4.4|252|V Retinoblastoma|57293473|0-14|All Races|Male and Female|2001|||
7.8|9.3|8.5|487|VI Renal tumors|57293473|0-14|All Races|Male and Female|2001|||
7.4|8.9|8.2|465|VI(a) Nephroblastoma and other nonepithelial renal tumors|57293473|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|57293473|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|119|VII Hepatic tumors|57293473|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|96|VII(a) Hepatoblastoma|57293473|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|57293473|0-14|All Races|Male and Female|2001|||
6.2|7.6|6.9|397|VIII Malignant bone tumors|57293473|0-14|All Races|Male and Female|2001|||
3.2|4.3|3.7|215|VIII(a) Osteosarcomas|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|57293473|0-14|All Races|Male and Female|2001|||
2.3|3.2|2.7|156|VIII(c) Ewing tumor and related sarcomas of bone|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|57293473|0-14|All Races|Male and Female|2001|||
4.5|5.6|5.0|292|X Germ cell, trophoblastic tumors & neoplasms of gonads|57293473|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|74|X(a) Intracranial & intraspinal germ cell tumors|57293473|0-14|All Races|Male and Female|2001|||
1.1|1.7|1.4|81|X(b) Malignant extracranial & extragonadal germ cell tumors|57293473|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|119|X(c) Malignant gonadal germ cell tumors|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|57293473|0-14|All Races|Male and Female|2001|||
6.1|7.4|6.7|389|XI Other malignant epithelial neoplasms and malignant melanomas|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(a) Adrenocortical carcinomas|57293473|0-14|All Races|Male and Female|2001|||
2.0|2.8|2.4|137|XI(b) Thyroid carcinomas|57293473|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|57293473|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|117|XI(d) Malignant melanomas|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|57293473|0-14|All Races|Male and Female|2001|||
1.4|2.1|1.7|98|XI(f) Other and unspecified carcinomas|57293473|0-14|All Races|Male and Female|2001|||
0.4|0.8|0.6|32|XII Other and unspecified malignant neoplasms|57293473|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|57293473|0-14|All Races|Male and Female|2001|||
~|~|~|~|XII(b) Other unspecified malignant tumors|57293473|0-14|All Races|Male and Female|2001|||
150.1|156.5|153.3|9034|All ICCC Groups Combined|58853101|0-14|All Races|Male and Female|2002|||
47.2|50.8|49.0|2879|I Leukemias, myeloproliferative & myelodysplastic diseases|58853101|0-14|All Races|Male and Female|2002|||
35.1|38.2|36.6|2148|I(a) Lymphoid leukemias|58853101|0-14|All Races|Male and Female|2002|||
7.2|8.6|7.9|467|I(b) Acute myeloid leukemias|58853101|0-14|All Races|Male and Female|2002|||
1.3|2.0|1.6|96|I(c) Chronic myeloproliferative diseases|58853101|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58853101|0-14|All Races|Male and Female|2002|||
1.0|1.6|1.3|76|I(e) Unspecified and other specified leukemias|58853101|0-14|All Races|Male and Female|2002|||
14.6|16.6|15.6|923|II Lymphomas and reticuloendothelial neoplasms|58853101|0-14|All Races|Male and Female|2002|||
4.9|6.1|5.5|328|II(a) Hodgkin lymphomas|58853101|0-14|All Races|Male and Female|2002|||
5.5|6.7|6.1|358|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58853101|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.7|161|II(c) Burkitt lymphoma|58853101|0-14|All Races|Male and Female|2002|||
0.8|1.4|1.1|65|II(d) Miscellaneous lymphoreticular neoplasms|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|58853101|0-14|All Races|Male and Female|2002|||
32.3|35.3|33.8|1982|III CNS and misc intracranial and intraspinal neoplasms|58853101|0-14|All Races|Male and Female|2002|||
3.1|4.1|3.5|209|III(a) Ependymomas and choroid plexus tumor|58853101|0-14|All Races|Male and Female|2002|||
14.8|16.9|15.8|929|III(b) Astrocytomas|58853101|0-14|All Races|Male and Female|2002|||
6.7|8.1|7.4|433|III(c) Intracranial and intraspinal embryonal tumors|58853101|0-14|All Races|Male and Female|2002|||
5.2|6.5|5.8|342|III(d) Other gliomas|58853101|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|43|III(e) Other specified intracranial & intraspinal neoplasms|58853101|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|26|III(f) Unspecified intracranial and intraspinal neoplasms|58853101|0-14|All Races|Male and Female|2002|||
10.0|11.7|10.8|641|IV Neuroblastoma and other peripheral nervous cell tumors|58853101|0-14|All Races|Male and Female|2002|||
9.9|11.6|10.7|635|IV(a) Neuroblastoma and ganglioneuroblastoma|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|58853101|0-14|All Races|Male and Female|2002|||
10.0|11.7|10.8|637|IX Soft tissue and other extraosseous sarcomas|58853101|0-14|All Races|Male and Female|2002|||
4.7|5.9|5.3|311|IX(a) Rhabdomyosarcomas|58853101|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.2|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|58853101|0-14|All Races|Male and Female|2002|||
3.0|3.9|3.4|203|IX(d) Other specified soft tissue sarcomas|58853101|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|58853101|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|24|Not classified by ICCC|58853101|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.7|219|V Retinoblastoma|58853101|0-14|All Races|Male and Female|2002|||
7.5|9.0|8.2|482|VI Renal tumors|58853101|0-14|All Races|Male and Female|2002|||
7.3|8.7|8.0|469|VI(a) Nephroblastoma and other nonepithelial renal tumors|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|58853101|0-14|All Races|Male and Female|2002|||
1.5|2.3|1.9|111|VII Hepatic tumors|58853101|0-14|All Races|Male and Female|2002|||
1.2|1.9|1.5|91|VII(a) Hepatoblastoma|58853101|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58853101|0-14|All Races|Male and Female|2002|||
6.2|7.6|6.9|408|VIII Malignant bone tumors|58853101|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.7|220|VIII(a) Osteosarcomas|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|58853101|0-14|All Races|Male and Female|2002|||
2.2|3.0|2.6|152|VIII(c) Ewing tumor and related sarcomas of bone|58853101|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.4|21|VIII(d) Other specified malignant bone tumors|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|58853101|0-14|All Races|Male and Female|2002|||
4.7|5.9|5.3|315|X Germ cell, trophoblastic tumors & neoplasms of gonads|58853101|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|86|X(a) Intracranial & intraspinal germ cell tumors|58853101|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|88|X(b) Malignant extracranial & extragonadal germ cell tumors|58853101|0-14|All Races|Male and Female|2002|||
1.9|2.6|2.2|132|X(c) Malignant gonadal germ cell tumors|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58853101|0-14|All Races|Male and Female|2002|||
5.8|7.1|6.4|382|XI Other malignant epithelial neoplasms and malignant melanomas|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|58853101|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|116|XI(b) Thyroid carcinomas|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|58853101|0-14|All Races|Male and Female|2002|||
1.9|2.6|2.2|132|XI(d) Malignant melanomas|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|58853101|0-14|All Races|Male and Female|2002|||
1.4|2.0|1.7|100|XI(f) Other and unspecified carcinomas|58853101|0-14|All Races|Male and Female|2002|||
0.4|0.7|0.5|31|XII Other and unspecified malignant neoplasms|58853101|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|58853101|0-14|All Races|Male and Female|2002|||
~|~|~|~|XII(b) Other unspecified malignant tumors|58853101|0-14|All Races|Male and Female|2002|||
146.9|153.0|149.9|9175|All ICCC Groups Combined|60910921|0-14|All Races|Male and Female|2003|||
45.2|48.7|46.9|2862|I Leukemias, myeloproliferative & myelodysplastic diseases|60910921|0-14|All Races|Male and Female|2003|||
34.0|37.0|35.5|2161|I(a) Lymphoid leukemias|60910921|0-14|All Races|Male and Female|2003|||
6.7|8.1|7.4|453|I(b) Acute myeloid leukemias|60910921|0-14|All Races|Male and Female|2003|||
1.0|1.6|1.3|81|I(c) Chronic myeloproliferative diseases|60910921|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|110|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60910921|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|57|I(e) Unspecified and other specified leukemias|60910921|0-14|All Races|Male and Female|2003|||
15.0|17.0|15.9|973|II Lymphomas and reticuloendothelial neoplasms|60910921|0-14|All Races|Male and Female|2003|||
5.3|6.5|5.9|360|II(a) Hodgkin lymphomas|60910921|0-14|All Races|Male and Female|2003|||
5.6|6.9|6.2|380|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60910921|0-14|All Races|Male and Female|2003|||
2.3|3.1|2.7|162|II(c) Burkitt lymphoma|60910921|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.0|64|II(d) Miscellaneous lymphoreticular neoplasms|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|60910921|0-14|All Races|Male and Female|2003|||
30.7|33.6|32.2|1958|III CNS and misc intracranial and intraspinal neoplasms|60910921|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|151|III(a) Ependymomas and choroid plexus tumor|60910921|0-14|All Races|Male and Female|2003|||
15.0|17.0|16.0|974|III(b) Astrocytomas|60910921|0-14|All Races|Male and Female|2003|||
6.5|7.8|7.1|433|III(c) Intracranial and intraspinal embryonal tumors|60910921|0-14|All Races|Male and Female|2003|||
4.9|6.1|5.5|333|III(d) Other gliomas|60910921|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.8|48|III(e) Other specified intracranial & intraspinal neoplasms|60910921|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|19|III(f) Unspecified intracranial and intraspinal neoplasms|60910921|0-14|All Races|Male and Female|2003|||
9.8|11.4|10.5|652|IV Neuroblastoma and other peripheral nervous cell tumors|60910921|0-14|All Races|Male and Female|2003|||
9.6|11.2|10.4|643|IV(a) Neuroblastoma and ganglioneuroblastoma|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60910921|0-14|All Races|Male and Female|2003|||
9.7|11.3|10.5|643|IX Soft tissue and other extraosseous sarcomas|60910921|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|310|IX(a) Rhabdomyosarcomas|60910921|0-14|All Races|Male and Female|2003|||
0.7|1.3|1.0|60|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|60910921|0-14|All Races|Male and Female|2003|||
3.0|3.9|3.4|212|IX(d) Other specified soft tissue sarcomas|60910921|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60910921|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|16|Not classified by ICCC|60910921|0-14|All Races|Male and Female|2003|||
3.5|4.5|3.9|245|V Retinoblastoma|60910921|0-14|All Races|Male and Female|2003|||
7.7|9.2|8.4|515|VI Renal tumors|60910921|0-14|All Races|Male and Female|2003|||
7.3|8.7|8.0|490|VI(a) Nephroblastoma and other nonepithelial renal tumors|60910921|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60910921|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.4|151|VII Hepatic tumors|60910921|0-14|All Races|Male and Female|2003|||
1.7|2.4|2.0|124|VII(a) Hepatoblastoma|60910921|0-14|All Races|Male and Female|2003|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60910921|0-14|All Races|Male and Female|2003|||
6.0|7.3|6.7|409|VIII Malignant bone tumors|60910921|0-14|All Races|Male and Female|2003|||
3.3|4.3|3.7|230|VIII(a) Osteosarcomas|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|60910921|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|135|VIII(c) Ewing tumor and related sarcomas of bone|60910921|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60910921|0-14|All Races|Male and Female|2003|||
4.5|5.6|5.0|312|X Germ cell, trophoblastic tumors & neoplasms of gonads|60910921|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|73|X(a) Intracranial & intraspinal germ cell tumors|60910921|0-14|All Races|Male and Female|2003|||
1.1|1.7|1.4|88|X(b) Malignant extracranial & extragonadal germ cell tumors|60910921|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|135|X(c) Malignant gonadal germ cell tumors|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60910921|0-14|All Races|Male and Female|2003|||
5.8|7.0|6.4|393|XI Other malignant epithelial neoplasms and malignant melanomas|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60910921|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|135|XI(b) Thyroid carcinomas|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60910921|0-14|All Races|Male and Female|2003|||
1.6|2.3|1.9|120|XI(d) Malignant melanomas|60910921|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|60910921|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|110|XI(f) Other and unspecified carcinomas|60910921|0-14|All Races|Male and Female|2003|||
0.5|1.0|0.7|46|XII Other and unspecified malignant neoplasms|60910921|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60910921|0-14|All Races|Male and Female|2003|||
0.3|0.6|0.4|26|XII(b) Other unspecified malignant tumors|60910921|0-14|All Races|Male and Female|2003|||
154.2|160.5|157.4|9673|All ICCC Groups Combined|61011791|0-14|All Races|Male and Female|2004|||
48.5|52.1|50.3|3087|I Leukemias, myeloproliferative & myelodysplastic diseases|61011791|0-14|All Races|Male and Female|2004|||
36.5|39.6|38.1|2333|I(a) Lymphoid leukemias|61011791|0-14|All Races|Male and Female|2004|||
7.2|8.6|7.9|485|I(b) Acute myeloid leukemias|61011791|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|90|I(c) Chronic myeloproliferative diseases|61011791|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61011791|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|86|I(e) Unspecified and other specified leukemias|61011791|0-14|All Races|Male and Female|2004|||
15.2|17.2|16.1|987|II Lymphomas and reticuloendothelial neoplasms|61011791|0-14|All Races|Male and Female|2004|||
4.8|6.0|5.4|329|II(a) Hodgkin lymphomas|61011791|0-14|All Races|Male and Female|2004|||
6.2|7.5|6.8|415|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61011791|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|149|II(c) Burkitt lymphoma|61011791|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.2|78|II(d) Miscellaneous lymphoreticular neoplasms|61011791|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|16|II(e) Unspecified lymphomas|61011791|0-14|All Races|Male and Female|2004|||
32.5|35.4|33.9|2072|III CNS and misc intracranial and intraspinal neoplasms|61011791|0-14|All Races|Male and Female|2004|||
2.5|3.4|2.9|181|III(a) Ependymomas and choroid plexus tumor|61011791|0-14|All Races|Male and Female|2004|||
15.7|17.8|16.7|1020|III(b) Astrocytomas|61011791|0-14|All Races|Male and Female|2004|||
7.0|8.4|7.7|469|III(c) Intracranial and intraspinal embryonal tumors|61011791|0-14|All Races|Male and Female|2004|||
4.8|5.9|5.3|322|III(d) Other gliomas|61011791|0-14|All Races|Male and Female|2004|||
0.6|1.0|0.8|47|III(e) Other specified intracranial & intraspinal neoplasms|61011791|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.5|33|III(f) Unspecified intracranial and intraspinal neoplasms|61011791|0-14|All Races|Male and Female|2004|||
10.0|11.6|10.8|673|IV Neuroblastoma and other peripheral nervous cell tumors|61011791|0-14|All Races|Male and Female|2004|||
9.7|11.4|10.5|659|IV(a) Neuroblastoma and ganglioneuroblastoma|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61011791|0-14|All Races|Male and Female|2004|||
9.7|11.3|10.5|644|IX Soft tissue and other extraosseous sarcomas|61011791|0-14|All Races|Male and Female|2004|||
4.1|5.2|4.6|285|IX(a) Rhabdomyosarcomas|61011791|0-14|All Races|Male and Female|2004|||
1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|61011791|0-14|All Races|Male and Female|2004|||
3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|61011791|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|62|IX(e) Unspecified soft tissue sarcomas|61011791|0-14|All Races|Male and Female|2004|||
0.1|0.4|0.3|16|Not classified by ICCC|61011791|0-14|All Races|Male and Female|2004|||
3.7|4.7|4.2|265|V Retinoblastoma|61011791|0-14|All Races|Male and Female|2004|||
7.3|8.7|8.0|493|VI Renal tumors|61011791|0-14|All Races|Male and Female|2004|||
6.9|8.3|7.6|471|VI(a) Nephroblastoma and other nonepithelial renal tumors|61011791|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.4|22|VI(b) Renal carcinomas|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61011791|0-14|All Races|Male and Female|2004|||
2.2|3.0|2.6|163|VII Hepatic tumors|61011791|0-14|All Races|Male and Female|2004|||
1.9|2.7|2.3|143|VII(a) Hepatoblastoma|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61011791|0-14|All Races|Male and Female|2004|||
6.5|7.9|7.1|437|VIII Malignant bone tumors|61011791|0-14|All Races|Male and Female|2004|||
3.6|4.7|4.1|253|VIII(a) Osteosarcomas|61011791|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|61011791|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|145|VIII(c) Ewing tumor and related sarcomas of bone|61011791|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61011791|0-14|All Races|Male and Female|2004|||
5.0|6.2|5.6|348|X Germ cell, trophoblastic tumors & neoplasms of gonads|61011791|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|97|X(a) Intracranial & intraspinal germ cell tumors|61011791|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|61011791|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|149|X(c) Malignant gonadal germ cell tumors|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61011791|0-14|All Races|Male and Female|2004|||
6.6|8.0|7.3|447|XI Other malignant epithelial neoplasms and malignant melanomas|61011791|0-14|All Races|Male and Female|2004|||
0.1|0.4|0.3|16|XI(a) Adrenocortical carcinomas|61011791|0-14|All Races|Male and Female|2004|||
2.2|3.0|2.6|156|XI(b) Thyroid carcinomas|61011791|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|61011791|0-14|All Races|Male and Female|2004|||
2.1|3.0|2.5|155|XI(d) Malignant melanomas|61011791|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|61011791|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|90|XI(f) Other and unspecified carcinomas|61011791|0-14|All Races|Male and Female|2004|||
0.5|0.9|0.7|41|XII Other and unspecified malignant neoplasms|61011791|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|61011791|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|61011791|0-14|All Races|Male and Female|2004|||
153.6|156.4|155.0|47885|All ICCC Groups Combined|305851887|0-14|All Races|Male and Female|2004-2008|||
49.0|50.6|49.8|15435|I Leukemias, myeloproliferative & myelodysplastic diseases|305851887|0-14|All Races|Male and Female|2004-2008|||
37.2|38.5|37.8|11721|I(a) Lymphoid leukemias|305851887|0-14|All Races|Male and Female|2004-2008|||
7.2|7.9|7.5|2337|I(b) Acute myeloid leukemias|305851887|0-14|All Races|Male and Female|2004-2008|||
1.4|1.7|1.6|486|I(c) Chronic myeloproliferative diseases|305851887|0-14|All Races|Male and Female|2004-2008|||
1.4|1.7|1.5|483|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|305851887|0-14|All Races|Male and Female|2004-2008|||
1.2|1.4|1.3|408|I(e) Unspecified and other specified leukemias|305851887|0-14|All Races|Male and Female|2004-2008|||
16.0|17.0|16.5|5009|II Lymphomas and reticuloendothelial neoplasms|305851887|0-14|All Races|Male and Female|2004-2008|||
5.6|6.1|5.9|1764|II(a) Hodgkin lymphomas|305851887|0-14|All Races|Male and Female|2004-2008|||
6.3|6.9|6.6|2010|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|305851887|0-14|All Races|Male and Female|2004-2008|||
2.4|2.7|2.5|771|II(c) Burkitt lymphoma|305851887|0-14|All Races|Male and Female|2004-2008|||
1.1|1.4|1.2|393|II(d) Miscellaneous lymphoreticular neoplasms|305851887|0-14|All Races|Male and Female|2004-2008|||
0.2|0.3|0.2|71|II(e) Unspecified lymphomas|305851887|0-14|All Races|Male and Female|2004-2008|||
32.1|33.4|32.7|10054|III CNS and misc intracranial and intraspinal neoplasms|305851887|0-14|All Races|Male and Female|2004-2008|||
2.7|3.1|2.9|893|III(a) Ependymomas and choroid plexus tumor|305851887|0-14|All Races|Male and Female|2004-2008|||
15.4|16.3|15.8|4854|III(b) Astrocytomas|305851887|0-14|All Races|Male and Female|2004-2008|||
7.1|7.7|7.4|2292|III(c) Intracranial and intraspinal embryonal tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
5.2|5.7|5.4|1651|III(d) Other gliomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.6|0.8|0.7|204|III(e) Other specified intracranial & intraspinal neoplasms|305851887|0-14|All Races|Male and Female|2004-2008|||
0.4|0.6|0.5|160|III(f) Unspecified intracranial and intraspinal neoplasms|305851887|0-14|All Races|Male and Female|2004-2008|||
10.3|11.0|10.6|3383|IV Neuroblastoma and other peripheral nervous cell tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
10.1|10.8|10.5|3333|IV(a) Neuroblastoma and ganglioneuroblastoma|305851887|0-14|All Races|Male and Female|2004-2008|||
0.1|0.2|0.2|50|IV(b) Other peripheral nervous cell tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
10.1|10.9|10.5|3228|IX Soft tissue and other extraosseous sarcomas|305851887|0-14|All Races|Male and Female|2004-2008|||
4.8|5.3|5.0|1556|IX(a) Rhabdomyosarcomas|305851887|0-14|All Races|Male and Female|2004-2008|||
1.0|1.2|1.1|335|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|305851887|0-14|All Races|Male and Female|2004-2008|||
~|~|~|~|IX(c) Kaposi sarcoma|305851887|0-14|All Races|Male and Female|2004-2008|||
3.2|3.6|3.4|1030|IX(d) Other specified soft tissue sarcomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.9|1.1|1.0|300|IX(e) Unspecified soft tissue sarcomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.2|0.3|0.3|78|Not classified by ICCC|305851887|0-14|All Races|Male and Female|2004-2008|||
3.7|4.2|3.9|1266|V Retinoblastoma|305851887|0-14|All Races|Male and Female|2004-2008|||
7.8|8.5|8.1|2558|VI Renal tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
7.4|8.0|7.7|2435|VI(a) Nephroblastoma and other nonepithelial renal tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
0.3|0.4|0.4|112|VI(b) Renal carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
2.3|2.7|2.5|788|VII Hepatic tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
1.9|2.3|2.1|673|VII(a) Hepatoblastoma|305851887|0-14|All Races|Male and Female|2004-2008|||
0.3|0.4|0.3|104|VII(b) Hepatic carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
6.6|7.2|6.9|2085|VIII Malignant bone tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
3.7|4.1|3.9|1170|VIII(a) Osteosarcomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.1|0.2|0.2|54|VIII(b) Chondrosarcomas|305851887|0-14|All Races|Male and Female|2004-2008|||
2.2|2.6|2.4|730|VIII(c) Ewing tumor and related sarcomas of bone|305851887|0-14|All Races|Male and Female|2004-2008|||
0.2|0.3|0.3|81|VIII(d) Other specified malignant bone tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
0.1|0.2|0.2|50|VIII(e) Unspecified malignant bone tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
5.1|5.6|5.3|1642|X Germ cell, trophoblastic tumors & neoplasms of gonads|305851887|0-14|All Races|Male and Female|2004-2008|||
1.2|1.5|1.4|418|X(a) Intracranial & intraspinal germ cell tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
1.2|1.5|1.4|439|X(b) Malignant extracranial & extragonadal germ cell tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
2.1|2.5|2.3|709|X(c) Malignant gonadal germ cell tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
0.1|0.2|0.1|35|X(d) Gonadal carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.1|0.2|0.1|41|X(e) Other and unspecified malignant gonadal tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
6.8|7.4|7.1|2159|XI Other malignant epithelial neoplasms and malignant melanomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.2|0.3|0.2|64|XI(a) Adrenocortical carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
2.2|2.6|2.4|725|XI(b) Thyroid carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.2|0.4|0.3|89|XI(c) Nasopharyngeal carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
2.2|2.6|2.4|727|XI(d) Malignant melanomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.0|0.1|0.1|20|XI(e) Skin carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
1.6|1.9|1.8|534|XI(f) Other and unspecified carcinomas|305851887|0-14|All Races|Male and Female|2004-2008|||
0.6|0.7|0.6|200|XII Other and unspecified malignant neoplasms|305851887|0-14|All Races|Male and Female|2004-2008|||
0.3|0.4|0.3|109|XII(a) Other specified malignant tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
0.2|0.4|0.3|91|XII(b) Other unspecified malignant tumors|305851887|0-14|All Races|Male and Female|2004-2008|||
149.6|155.8|152.7|9395|All ICCC Groups Combined|60953039|0-14|All Races|Male and Female|2005|||
46.7|50.2|48.5|2987|I Leukemias, myeloproliferative & myelodysplastic diseases|60953039|0-14|All Races|Male and Female|2005|||
35.5|38.6|37.0|2279|I(a) Lymphoid leukemias|60953039|0-14|All Races|Male and Female|2005|||
6.5|7.9|7.2|445|I(b) Acute myeloid leukemias|60953039|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.3|82|I(c) Chronic myeloproliferative diseases|60953039|0-14|All Races|Male and Female|2005|||
1.3|1.9|1.6|97|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60953039|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|84|I(e) Unspecified and other specified leukemias|60953039|0-14|All Races|Male and Female|2005|||
15.7|17.7|16.7|1015|II Lymphomas and reticuloendothelial neoplasms|60953039|0-14|All Races|Male and Female|2005|||
5.4|6.7|6.0|366|II(a) Hodgkin lymphomas|60953039|0-14|All Races|Male and Female|2005|||
5.8|7.1|6.5|393|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60953039|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60953039|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|88|II(d) Miscellaneous lymphoreticular neoplasms|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60953039|0-14|All Races|Male and Female|2005|||
30.1|33.0|31.5|1925|III CNS and misc intracranial and intraspinal neoplasms|60953039|0-14|All Races|Male and Female|2005|||
2.8|3.7|3.2|197|III(a) Ependymomas and choroid plexus tumor|60953039|0-14|All Races|Male and Female|2005|||
14.7|16.7|15.7|959|III(b) Astrocytomas|60953039|0-14|All Races|Male and Female|2005|||
6.1|7.5|6.8|414|III(c) Intracranial and intraspinal embryonal tumors|60953039|0-14|All Races|Male and Female|2005|||
4.3|5.4|4.8|292|III(d) Other gliomas|60953039|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|60953039|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|27|III(f) Unspecified intracranial and intraspinal neoplasms|60953039|0-14|All Races|Male and Female|2005|||
10.6|12.3|11.4|721|IV Neuroblastoma and other peripheral nervous cell tumors|60953039|0-14|All Races|Male and Female|2005|||
10.5|12.2|11.3|712|IV(a) Neuroblastoma and ganglioneuroblastoma|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60953039|0-14|All Races|Male and Female|2005|||
9.7|11.4|10.5|642|IX Soft tissue and other extraosseous sarcomas|60953039|0-14|All Races|Male and Female|2005|||
4.7|5.9|5.2|321|IX(a) Rhabdomyosarcomas|60953039|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60953039|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60953039|0-14|All Races|Male and Female|2005|||
0.6|1.1|0.8|48|IX(e) Unspecified soft tissue sarcomas|60953039|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|21|Not classified by ICCC|60953039|0-14|All Races|Male and Female|2005|||
3.3|4.3|3.7|238|V Retinoblastoma|60953039|0-14|All Races|Male and Female|2005|||
7.3|8.8|8.0|500|VI Renal tumors|60953039|0-14|All Races|Male and Female|2005|||
7.0|8.3|7.6|476|VI(a) Nephroblastoma and other nonepithelial renal tumors|60953039|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60953039|0-14|All Races|Male and Female|2005|||
1.9|2.7|2.3|143|VII Hepatic tumors|60953039|0-14|All Races|Male and Female|2005|||
1.5|2.2|1.8|115|VII(a) Hepatoblastoma|60953039|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60953039|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|412|VIII Malignant bone tumors|60953039|0-14|All Races|Male and Female|2005|||
3.3|4.3|3.7|226|VIII(a) Osteosarcomas|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60953039|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60953039|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60953039|0-14|All Races|Male and Female|2005|||
4.9|6.0|5.4|336|X Germ cell, trophoblastic tumors & neoplasms of gonads|60953039|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.3|82|X(a) Intracranial & intraspinal germ cell tumors|60953039|0-14|All Races|Male and Female|2005|||
1.3|1.9|1.6|99|X(b) Malignant extracranial & extragonadal germ cell tumors|60953039|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|138|X(c) Malignant gonadal germ cell tumors|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60953039|0-14|All Races|Male and Female|2005|||
6.3|7.6|6.9|421|XI Other malignant epithelial neoplasms and malignant melanomas|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60953039|0-14|All Races|Male and Female|2005|||
1.8|2.5|2.1|130|XI(b) Thyroid carcinomas|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60953039|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.4|149|XI(d) Malignant melanomas|60953039|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60953039|0-14|All Races|Male and Female|2005|||
1.6|2.3|2.0|119|XI(f) Other and unspecified carcinomas|60953039|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|34|XII Other and unspecified malignant neoplasms|60953039|0-14|All Races|Male and Female|2005|||
0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|60953039|0-14|All Races|Male and Female|2005|||
0.2|0.4|0.3|17|XII(b) Other unspecified malignant tumors|60953039|0-14|All Races|Male and Female|2005|||
151.0|157.3|154.1|9498|All ICCC Groups Combined|61022964|0-14|All Races|Male and Female|2006|||
48.2|51.8|50.0|3088|I Leukemias, myeloproliferative & myelodysplastic diseases|61022964|0-14|All Races|Male and Female|2006|||
36.3|39.4|37.8|2334|I(a) Lymphoid leukemias|61022964|0-14|All Races|Male and Female|2006|||
6.9|8.3|7.6|470|I(b) Acute myeloid leukemias|61022964|0-14|All Races|Male and Female|2006|||
1.3|1.9|1.6|97|I(c) Chronic myeloproliferative diseases|61022964|0-14|All Races|Male and Female|2006|||
1.3|2.0|1.7|103|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61022964|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.4|84|I(e) Unspecified and other specified leukemias|61022964|0-14|All Races|Male and Female|2006|||
15.6|17.6|16.6|1005|II Lymphomas and reticuloendothelial neoplasms|61022964|0-14|All Races|Male and Female|2006|||
5.6|6.9|6.2|373|II(a) Hodgkin lymphomas|61022964|0-14|All Races|Male and Female|2006|||
5.8|7.1|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61022964|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|146|II(c) Burkitt lymphoma|61022964|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.3|84|II(d) Miscellaneous lymphoreticular neoplasms|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|61022964|0-14|All Races|Male and Female|2006|||
31.1|34.0|32.5|1992|III CNS and misc intracranial and intraspinal neoplasms|61022964|0-14|All Races|Male and Female|2006|||
2.6|3.5|3.0|185|III(a) Ependymomas and choroid plexus tumor|61022964|0-14|All Races|Male and Female|2006|||
14.5|16.5|15.5|949|III(b) Astrocytomas|61022964|0-14|All Races|Male and Female|2006|||
6.8|8.2|7.5|460|III(c) Intracranial and intraspinal embryonal tumors|61022964|0-14|All Races|Male and Female|2006|||
4.8|6.0|5.3|324|III(d) Other gliomas|61022964|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|61022964|0-14|All Races|Male and Female|2006|||
0.5|0.9|0.7|43|III(f) Unspecified intracranial and intraspinal neoplasms|61022964|0-14|All Races|Male and Female|2006|||
9.1|10.6|9.8|624|IV Neuroblastoma and other peripheral nervous cell tumors|61022964|0-14|All Races|Male and Female|2006|||
9.0|10.6|9.8|619|IV(a) Neuroblastoma and ganglioneuroblastoma|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61022964|0-14|All Races|Male and Female|2006|||
9.6|11.2|10.4|635|IX Soft tissue and other extraosseous sarcomas|61022964|0-14|All Races|Male and Female|2006|||
4.2|5.3|4.8|293|IX(a) Rhabdomyosarcomas|61022964|0-14|All Races|Male and Female|2006|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|61022964|0-14|All Races|Male and Female|2006|||
2.9|3.9|3.4|207|IX(d) Other specified soft tissue sarcomas|61022964|0-14|All Races|Male and Female|2006|||
0.8|1.3|1.0|64|IX(e) Unspecified soft tissue sarcomas|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|61022964|0-14|All Races|Male and Female|2006|||
3.4|4.4|3.9|248|V Retinoblastoma|61022964|0-14|All Races|Male and Female|2006|||
7.3|8.7|8.0|501|VI Renal tumors|61022964|0-14|All Races|Male and Female|2006|||
7.0|8.3|7.6|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|61022964|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VI(b) Renal carcinomas|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61022964|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|160|VII Hepatic tumors|61022964|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|134|VII(a) Hepatoblastoma|61022964|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61022964|0-14|All Races|Male and Female|2006|||
6.4|7.8|7.1|425|VIII Malignant bone tumors|61022964|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.1|245|VIII(a) Osteosarcomas|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|61022964|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|143|VIII(c) Ewing tumor and related sarcomas of bone|61022964|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61022964|0-14|All Races|Male and Female|2006|||
4.4|5.6|5.0|307|X Germ cell, trophoblastic tumors & neoplasms of gonads|61022964|0-14|All Races|Male and Female|2006|||
1.0|1.5|1.2|74|X(a) Intracranial & intraspinal germ cell tumors|61022964|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.4|91|X(b) Malignant extracranial & extragonadal germ cell tumors|61022964|0-14|All Races|Male and Female|2006|||
1.7|2.5|2.1|127|X(c) Malignant gonadal germ cell tumors|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61022964|0-14|All Races|Male and Female|2006|||
6.8|8.2|7.5|454|XI Other malignant epithelial neoplasms and malignant melanomas|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61022964|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|157|XI(b) Thyroid carcinomas|61022964|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|61022964|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|151|XI(d) Malignant melanomas|61022964|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|61022964|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.8|109|XI(f) Other and unspecified carcinomas|61022964|0-14|All Races|Male and Female|2006|||
0.6|1.0|0.8|47|XII Other and unspecified malignant neoplasms|61022964|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|61022964|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|20|XII(b) Other unspecified malignant tumors|61022964|0-14|All Races|Male and Female|2006|||
153.0|159.3|156.1|9685|All ICCC Groups Combined|61294588|0-14|All Races|Male and Female|2007|||
48.2|51.8|50.0|3112|I Leukemias, myeloproliferative & myelodysplastic diseases|61294588|0-14|All Races|Male and Female|2007|||
36.7|39.8|38.2|2382|I(a) Lymphoid leukemias|61294588|0-14|All Races|Male and Female|2007|||
6.8|8.2|7.5|464|I(b) Acute myeloid leukemias|61294588|0-14|All Races|Male and Female|2007|||
1.3|1.9|1.5|96|I(c) Chronic myeloproliferative diseases|61294588|0-14|All Races|Male and Female|2007|||
1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61294588|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.2|78|I(e) Unspecified and other specified leukemias|61294588|0-14|All Races|Male and Female|2007|||
15.5|17.5|16.5|997|II Lymphomas and reticuloendothelial neoplasms|61294588|0-14|All Races|Male and Female|2007|||
4.8|6.0|5.4|324|II(a) Hodgkin lymphomas|61294588|0-14|All Races|Male and Female|2007|||
6.3|7.7|7.0|423|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61294588|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.6|160|II(c) Burkitt lymphoma|61294588|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|76|II(d) Miscellaneous lymphoreticular neoplasms|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|II(e) Unspecified lymphomas|61294588|0-14|All Races|Male and Female|2007|||
32.0|34.9|33.5|2061|III CNS and misc intracranial and intraspinal neoplasms|61294588|0-14|All Races|Male and Female|2007|||
2.4|3.2|2.8|173|III(a) Ependymomas and choroid plexus tumor|61294588|0-14|All Races|Male and Female|2007|||
14.6|16.6|15.6|957|III(b) Astrocytomas|61294588|0-14|All Races|Male and Female|2007|||
6.9|8.3|7.5|468|III(c) Intracranial and intraspinal embryonal tumors|61294588|0-14|All Races|Male and Female|2007|||
5.6|6.9|6.3|383|III(d) Other gliomas|61294588|0-14|All Races|Male and Female|2007|||
0.5|1.0|0.7|46|III(e) Other specified intracranial & intraspinal neoplasms|61294588|0-14|All Races|Male and Female|2007|||
0.4|0.8|0.5|34|III(f) Unspecified intracranial and intraspinal neoplasms|61294588|0-14|All Races|Male and Female|2007|||
10.3|11.9|11.1|715|IV Neuroblastoma and other peripheral nervous cell tumors|61294588|0-14|All Races|Male and Female|2007|||
10.1|11.8|10.9|706|IV(a) Neuroblastoma and ganglioneuroblastoma|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61294588|0-14|All Races|Male and Female|2007|||
9.9|11.6|10.7|660|IX Soft tissue and other extraosseous sarcomas|61294588|0-14|All Races|Male and Female|2007|||
5.0|6.1|5.5|343|IX(a) Rhabdomyosarcomas|61294588|0-14|All Races|Male and Female|2007|||
0.8|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|61294588|0-14|All Races|Male and Female|2007|||
2.8|3.8|3.3|199|IX(d) Other specified soft tissue sarcomas|61294588|0-14|All Races|Male and Female|2007|||
0.6|1.1|0.8|49|IX(e) Unspecified soft tissue sarcomas|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|61294588|0-14|All Races|Male and Female|2007|||
3.5|4.5|4.0|259|V Retinoblastoma|61294588|0-14|All Races|Male and Female|2007|||
7.6|9.1|8.3|526|VI Renal tumors|61294588|0-14|All Races|Male and Female|2007|||
7.2|8.6|7.8|498|VI(a) Nephroblastoma and other nonepithelial renal tumors|61294588|0-14|All Races|Male and Female|2007|||
0.3|0.7|0.5|27|VI(b) Renal carcinomas|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61294588|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|159|VII Hepatic tumors|61294588|0-14|All Races|Male and Female|2007|||
1.8|2.6|2.2|141|VII(a) Hepatoblastoma|61294588|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61294588|0-14|All Races|Male and Female|2007|||
6.2|7.5|6.8|408|VIII Malignant bone tumors|61294588|0-14|All Races|Male and Female|2007|||
3.2|4.2|3.6|218|VIII(a) Osteosarcomas|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|61294588|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61294588|0-14|All Races|Male and Female|2007|||
4.9|6.0|5.4|335|X Germ cell, trophoblastic tumors & neoplasms of gonads|61294588|0-14|All Races|Male and Female|2007|||
1.2|1.8|1.4|87|X(a) Intracranial & intraspinal germ cell tumors|61294588|0-14|All Races|Male and Female|2007|||
1.0|1.5|1.2|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61294588|0-14|All Races|Male and Female|2007|||
2.1|3.0|2.5|155|X(c) Malignant gonadal germ cell tumors|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61294588|0-14|All Races|Male and Female|2007|||
6.0|7.3|6.6|401|XI Other malignant epithelial neoplasms and malignant melanomas|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61294588|0-14|All Races|Male and Female|2007|||
1.8|2.6|2.2|132|XI(b) Thyroid carcinomas|61294588|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|17|XI(c) Nasopharyngeal carcinomas|61294588|0-14|All Races|Male and Female|2007|||
1.8|2.6|2.2|133|XI(d) Malignant melanomas|61294588|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|61294588|0-14|All Races|Male and Female|2007|||
1.4|2.1|1.7|102|XI(f) Other and unspecified carcinomas|61294588|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.6|40|XII Other and unspecified malignant neoplasms|61294588|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.4|23|XII(a) Other specified malignant tumors|61294588|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XII(b) Other unspecified malignant tumors|61294588|0-14|All Races|Male and Female|2007|||
151.4|157.6|154.5|9634|All ICCC Groups Combined|61569505|0-14|All Races|Male and Female|2008|||
48.7|52.2|50.4|3161|I Leukemias, myeloproliferative & myelodysplastic diseases|61569505|0-14|All Races|Male and Female|2008|||
36.6|39.7|38.2|2393|I(a) Lymphoid leukemias|61569505|0-14|All Races|Male and Female|2008|||
6.9|8.3|7.5|473|I(b) Acute myeloid leukemias|61569505|0-14|All Races|Male and Female|2008|||
1.6|2.3|1.9|121|I(c) Chronic myeloproliferative diseases|61569505|0-14|All Races|Male and Female|2008|||
1.3|1.9|1.6|98|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61569505|0-14|All Races|Male and Female|2008|||
1.0|1.5|1.2|76|I(e) Unspecified and other specified leukemias|61569505|0-14|All Races|Male and Female|2008|||
15.6|17.6|16.6|1005|II Lymphomas and reticuloendothelial neoplasms|61569505|0-14|All Races|Male and Female|2008|||
5.6|6.9|6.2|372|II(a) Hodgkin lymphomas|61569505|0-14|All Races|Male and Female|2008|||
5.8|7.1|6.4|390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61569505|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.6|161|II(c) Burkitt lymphoma|61569505|0-14|All Races|Male and Female|2008|||
0.8|1.3|1.0|67|II(d) Miscellaneous lymphoreticular neoplasms|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|II(e) Unspecified lymphomas|61569505|0-14|All Races|Male and Female|2008|||
30.9|33.8|32.3|2004|III CNS and misc intracranial and intraspinal neoplasms|61569505|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.5|157|III(a) Ependymomas and choroid plexus tumor|61569505|0-14|All Races|Male and Female|2008|||
14.7|16.7|15.7|969|III(b) Astrocytomas|61569505|0-14|All Races|Male and Female|2008|||
7.0|8.4|7.7|481|III(c) Intracranial and intraspinal embryonal tumors|61569505|0-14|All Races|Male and Female|2008|||
4.8|6.0|5.4|330|III(d) Other gliomas|61569505|0-14|All Races|Male and Female|2008|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|61569505|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61569505|0-14|All Races|Male and Female|2008|||
9.3|10.8|10.0|650|IV Neuroblastoma and other peripheral nervous cell tumors|61569505|0-14|All Races|Male and Female|2008|||
9.1|10.6|9.8|637|IV(a) Neuroblastoma and ganglioneuroblastoma|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61569505|0-14|All Races|Male and Female|2008|||
9.7|11.3|10.5|647|IX Soft tissue and other extraosseous sarcomas|61569505|0-14|All Races|Male and Female|2008|||
4.5|5.6|5.0|314|IX(a) Rhabdomyosarcomas|61569505|0-14|All Races|Male and Female|2008|||
0.7|1.1|0.9|54|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|IX(c) Kaposi sarcoma|61569505|0-14|All Races|Male and Female|2008|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|61569505|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.2|77|IX(e) Unspecified soft tissue sarcomas|61569505|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|Not classified by ICCC|61569505|0-14|All Races|Male and Female|2008|||
3.4|4.4|3.9|256|V Retinoblastoma|61569505|0-14|All Races|Male and Female|2008|||
7.7|9.1|8.4|538|VI Renal tumors|61569505|0-14|All Races|Male and Female|2008|||
7.3|8.7|7.9|511|VI(a) Nephroblastoma and other nonepithelial renal tumors|61569505|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|25|VI(b) Renal carcinomas|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61569505|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.5|163|VII Hepatic tumors|61569505|0-14|All Races|Male and Female|2008|||
1.8|2.5|2.1|140|VII(a) Hepatoblastoma|61569505|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61569505|0-14|All Races|Male and Female|2008|||
6.1|7.4|6.7|403|VIII Malignant bone tumors|61569505|0-14|All Races|Male and Female|2008|||
3.3|4.4|3.8|228|VIII(a) Osteosarcomas|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(b) Chondrosarcomas|61569505|0-14|All Races|Male and Female|2008|||
2.0|2.8|2.4|144|VIII(c) Ewing tumor and related sarcomas of bone|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61569505|0-14|All Races|Male and Female|2008|||
4.5|5.7|5.1|316|X Germ cell, trophoblastic tumors & neoplasms of gonads|61569505|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.3|78|X(a) Intracranial & intraspinal germ cell tumors|61569505|0-14|All Races|Male and Female|2008|||
1.1|1.6|1.3|86|X(b) Malignant extracranial & extragonadal germ cell tumors|61569505|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|140|X(c) Malignant gonadal germ cell tumors|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(d) Gonadal carcinomas|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61569505|0-14|All Races|Male and Female|2008|||
6.6|7.9|7.2|436|XI Other malignant epithelial neoplasms and malignant melanomas|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61569505|0-14|All Races|Male and Female|2008|||
2.1|3.0|2.5|150|XI(b) Thyroid carcinomas|61569505|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.3|17|XI(c) Nasopharyngeal carcinomas|61569505|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|139|XI(d) Malignant melanomas|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(e) Skin carcinomas|61569505|0-14|All Races|Male and Female|2008|||
1.6|2.3|1.9|114|XI(f) Other and unspecified carcinomas|61569505|0-14|All Races|Male and Female|2008|||
0.4|0.8|0.6|38|XII Other and unspecified malignant neoplasms|61569505|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.4|23|XII(a) Other specified malignant tumors|61569505|0-14|All Races|Male and Female|2008|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61569505|0-14|All Races|Male and Female|2008|||
156.0|161.9|158.9|11507|All ICCC Groups Combined|72548146|0-19|All Races|Male and Female|1999|155.7|161.5|158.6
39.8|42.7|41.2|2988|I Leukemias, myeloproliferative & myelodysplastic diseases|72548146|0-19|All Races|Male and Female|1999|39.7|42.7|41.2
29.4|32.0|30.7|2226|I(a) Lymphoid leukemias|72548146|0-19|All Races|Male and Female|1999|29.4|32.0|30.7
7.5|8.8|8.1|587|I(b) Acute myeloid leukemias|72548146|0-19|All Races|Male and Female|1999|7.4|8.8|8.1
0.8|1.3|1.0|72|I(c) Chronic myeloproliferative diseases|72548146|0-19|All Races|Male and Female|1999|0.8|1.2|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|72548146|0-19|All Races|Male and Female|1999|~|~|~
1.0|1.6|1.3|92|I(e) Unspecified and other specified leukemias|72548146|0-19|All Races|Male and Female|1999|1.0|1.6|1.3
22.1|24.4|23.2|1682|II Lymphomas and reticuloendothelial neoplasms|72548146|0-19|All Races|Male and Female|1999|22.1|24.3|23.2
11.0|12.6|11.8|854|II(a) Hodgkin lymphomas|72548146|0-19|All Races|Male and Female|1999|11.0|12.6|11.8
7.1|8.4|7.7|557|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|72548146|0-19|All Races|Male and Female|1999|7.1|8.3|7.7
2.1|2.8|2.4|176|II(c) Burkitt lymphoma|72548146|0-19|All Races|Male and Female|1999|2.1|2.8|2.4
0.6|1.0|0.7|54|II(d) Miscellaneous lymphoreticular neoplasms|72548146|0-19|All Races|Male and Female|1999|0.6|1.0|0.7
0.4|0.8|0.6|41|II(e) Unspecified lymphomas|72548146|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
27.0|29.5|28.2|2048|III CNS and misc intracranial and intraspinal neoplasms|72548146|0-19|All Races|Male and Female|1999|27.0|29.5|28.2
2.2|2.9|2.5|183|III(a) Ependymomas and choroid plexus tumor|72548146|0-19|All Races|Male and Female|1999|2.2|2.9|2.5
12.4|14.1|13.2|958|III(b) Astrocytomas|72548146|0-19|All Races|Male and Female|1999|12.4|14.1|13.2
6.1|7.3|6.7|486|III(c) Intracranial and intraspinal embryonal tumors|72548146|0-19|All Races|Male and Female|1999|6.1|7.3|6.7
4.2|5.2|4.7|340|III(d) Other gliomas|72548146|0-19|All Races|Male and Female|1999|4.2|5.2|4.7
0.4|0.7|0.5|37|III(e) Other specified intracranial & intraspinal neoplasms|72548146|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
0.4|0.8|0.6|44|III(f) Unspecified intracranial and intraspinal neoplasms|72548146|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
7.5|8.9|8.2|588|IV Neuroblastoma and other peripheral nervous cell tumors|72548146|0-19|All Races|Male and Female|1999|7.5|8.8|8.1
7.2|8.6|7.9|567|IV(a) Neuroblastoma and ganglioneuroblastoma|72548146|0-19|All Races|Male and Female|1999|7.2|8.5|7.8
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|72548146|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.0|11.5|10.8|780|IX Soft tissue and other extraosseous sarcomas|72548146|0-19|All Races|Male and Female|1999|10.0|11.5|10.8
4.0|5.0|4.5|326|IX(a) Rhabdomyosarcomas|72548146|0-19|All Races|Male and Female|1999|4.0|5.0|4.5
0.9|1.4|1.1|82|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|72548146|0-19|All Races|Male and Female|1999|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|72548146|0-19|All Races|Male and Female|1999|~|~|~
3.4|4.4|3.9|281|IX(d) Other specified soft tissue sarcomas|72548146|0-19|All Races|Male and Female|1999|3.4|4.4|3.9
1.0|1.5|1.2|88|IX(e) Unspecified soft tissue sarcomas|72548146|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.2|0.5|0.3|23|Not classified by ICCC|72548146|0-19|All Races|Male and Female|1999|0.2|0.5|0.3
2.8|3.7|3.2|232|V Retinoblastoma|72548146|0-19|All Races|Male and Female|1999|2.8|3.6|3.2
5.8|7.0|6.4|463|VI Renal tumors|72548146|0-19|All Races|Male and Female|1999|5.8|7.0|6.4
5.3|6.4|5.8|420|VI(a) Nephroblastoma and other nonepithelial renal tumors|72548146|0-19|All Races|Male and Female|1999|5.2|6.4|5.8
0.4|0.7|0.5|39|VI(b) Renal carcinomas|72548146|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|72548146|0-19|All Races|Male and Female|1999|~|~|~
1.7|2.4|2.0|144|VII Hepatic tumors|72548146|0-19|All Races|Male and Female|1999|1.7|2.3|2.0
1.0|1.6|1.3|92|VII(a) Hepatoblastoma|72548146|0-19|All Races|Male and Female|1999|1.0|1.6|1.3
0.5|0.9|0.7|51|VII(b) Hepatic carcinomas|72548146|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|72548146|0-19|All Races|Male and Female|1999|~|~|~
8.2|9.6|8.9|641|VIII Malignant bone tumors|72548146|0-19|All Races|Male and Female|1999|8.2|9.5|8.8
4.6|5.7|5.1|372|VIII(a) Osteosarcomas|72548146|0-19|All Races|Male and Female|1999|4.6|5.7|5.1
0.2|0.5|0.4|27|VIII(b) Chondrosarcomas|72548146|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.3|3.1|2.7|195|VIII(c) Ewing tumor and related sarcomas of bone|72548146|0-19|All Races|Male and Female|1999|2.3|3.1|2.7
0.3|0.7|0.5|36|VIII(d) Other specified malignant bone tumors|72548146|0-19|All Races|Male and Female|1999|0.3|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|72548146|0-19|All Races|Male and Female|1999|~|~|~
9.5|11.0|10.2|738|X Germ cell, trophoblastic tumors & neoplasms of gonads|72548146|0-19|All Races|Male and Female|1999|9.5|10.9|10.2
1.2|1.7|1.4|103|X(a) Intracranial & intraspinal germ cell tumors|72548146|0-19|All Races|Male and Female|1999|1.2|1.7|1.4
1.1|1.7|1.4|99|X(b) Malignant extracranial & extragonadal germ cell tumors|72548146|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
6.2|7.4|6.8|488|X(c) Malignant gonadal germ cell tumors|72548146|0-19|All Races|Male and Female|1999|6.1|7.4|6.7
0.3|0.6|0.4|30|X(d) Gonadal carcinomas|72548146|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.1|0.4|0.2|18|X(e) Other and unspecified malignant gonadal tumors|72548146|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
14.7|16.5|15.6|1126|XI Other malignant epithelial neoplasms and malignant melanomas|72548146|0-19|All Races|Male and Female|1999|14.6|16.5|15.5
0.1|0.4|0.2|16|XI(a) Adrenocortical carcinomas|72548146|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
5.4|6.5|5.9|427|XI(b) Thyroid carcinomas|72548146|0-19|All Races|Male and Female|1999|5.3|6.5|5.9
0.4|0.8|0.6|41|XI(c) Nasopharyngeal carcinomas|72548146|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
4.3|5.4|4.8|348|XI(d) Malignant melanomas|72548146|0-19|All Races|Male and Female|1999|4.3|5.3|4.8
~|~|~|~|XI(e) Skin carcinomas|72548146|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.5|4.0|288|XI(f) Other and unspecified carcinomas|72548146|0-19|All Races|Male and Female|1999|3.5|4.5|4.0
0.6|1.0|0.7|54|XII Other and unspecified malignant neoplasms|72548146|0-19|All Races|Male and Female|1999|0.6|1.0|0.7
0.1|0.4|0.2|16|XII(a) Other specified malignant tumors|72548146|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
0.4|0.7|0.5|38|XII(b) Other unspecified malignant tumors|72548146|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
160.1|165.9|163.0|11881|All ICCC Groups Combined|73017204|0-19|All Races|Male and Female|2000|159.8|165.7|162.7
39.9|42.8|41.3|3008|I Leukemias, myeloproliferative & myelodysplastic diseases|73017204|0-19|All Races|Male and Female|2000|39.7|42.7|41.2
30.6|33.2|31.9|2322|I(a) Lymphoid leukemias|73017204|0-19|All Races|Male and Female|2000|30.5|33.1|31.8
6.5|7.8|7.1|518|I(b) Acute myeloid leukemias|73017204|0-19|All Races|Male and Female|2000|6.5|7.7|7.1
0.7|1.1|0.9|66|I(c) Chronic myeloproliferative diseases|73017204|0-19|All Races|Male and Female|2000|0.7|1.1|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|73017204|0-19|All Races|Male and Female|2000|~|~|~
1.0|1.5|1.3|92|I(e) Unspecified and other specified leukemias|73017204|0-19|All Races|Male and Female|2000|1.0|1.5|1.3
23.7|26.0|24.8|1814|II Lymphomas and reticuloendothelial neoplasms|73017204|0-19|All Races|Male and Female|2000|23.7|26.0|24.8
11.6|13.2|12.4|903|II(a) Hodgkin lymphomas|73017204|0-19|All Races|Male and Female|2000|11.6|13.2|12.4
7.5|8.8|8.1|592|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|73017204|0-19|All Races|Male and Female|2000|7.5|8.8|8.1
2.3|3.1|2.7|194|II(c) Burkitt lymphoma|73017204|0-19|All Races|Male and Female|2000|2.3|3.1|2.7
0.8|1.3|1.0|73|II(d) Miscellaneous lymphoreticular neoplasms|73017204|0-19|All Races|Male and Female|2000|0.8|1.3|1.0
0.5|0.9|0.7|52|II(e) Unspecified lymphomas|73017204|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
28.6|31.1|29.8|2177|III CNS and misc intracranial and intraspinal neoplasms|73017204|0-19|All Races|Male and Female|2000|28.6|31.1|29.8
2.0|2.7|2.4|172|III(a) Ependymomas and choroid plexus tumor|73017204|0-19|All Races|Male and Female|2000|2.0|2.7|2.4
14.6|16.4|15.5|1128|III(b) Astrocytomas|73017204|0-19|All Races|Male and Female|2000|14.6|16.4|15.4
5.9|7.1|6.5|475|III(c) Intracranial and intraspinal embryonal tumors|73017204|0-19|All Races|Male and Female|2000|5.9|7.1|6.5
3.9|4.9|4.4|320|III(d) Other gliomas|73017204|0-19|All Races|Male and Female|2000|3.9|4.9|4.4
0.3|0.7|0.5|35|III(e) Other specified intracranial & intraspinal neoplasms|73017204|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
0.5|0.9|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|73017204|0-19|All Races|Male and Female|2000|0.5|0.9|0.6
6.9|8.2|7.6|548|IV Neuroblastoma and other peripheral nervous cell tumors|73017204|0-19|All Races|Male and Female|2000|6.9|8.2|7.5
6.8|8.1|7.4|539|IV(a) Neuroblastoma and ganglioneuroblastoma|73017204|0-19|All Races|Male and Female|2000|6.8|8.0|7.4
~|~|~|~|IV(b) Other peripheral nervous cell tumors|73017204|0-19|All Races|Male and Female|2000|~|~|~
11.1|12.7|11.9|869|IX Soft tissue and other extraosseous sarcomas|73017204|0-19|All Races|Male and Female|2000|11.1|12.7|11.9
4.4|5.4|4.9|354|IX(a) Rhabdomyosarcomas|73017204|0-19|All Races|Male and Female|2000|4.4|5.4|4.8
1.0|1.5|1.2|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|73017204|0-19|All Races|Male and Female|2000|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|73017204|0-19|All Races|Male and Female|2000|~|~|~
4.0|4.9|4.4|323|IX(d) Other specified soft tissue sarcomas|73017204|0-19|All Races|Male and Female|2000|4.0|4.9|4.4
1.1|1.7|1.4|100|IX(e) Unspecified soft tissue sarcomas|73017204|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
~|~|~|~|Not classified by ICCC|73017204|0-19|All Races|Male and Female|2000|~|~|~
2.9|3.7|3.3|236|V Retinoblastoma|73017204|0-19|All Races|Male and Female|2000|2.8|3.7|3.2
6.2|7.4|6.8|493|VI Renal tumors|73017204|0-19|All Races|Male and Female|2000|6.2|7.4|6.8
5.8|6.9|6.3|458|VI(a) Nephroblastoma and other nonepithelial renal tumors|73017204|0-19|All Races|Male and Female|2000|5.7|6.9|6.3
0.3|0.6|0.5|34|VI(b) Renal carcinomas|73017204|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|73017204|0-19|All Races|Male and Female|2000|~|~|~
1.6|2.2|1.9|135|VII Hepatic tumors|73017204|0-19|All Races|Male and Female|2000|1.6|2.2|1.8
1.2|1.8|1.5|108|VII(a) Hepatoblastoma|73017204|0-19|All Races|Male and Female|2000|1.2|1.8|1.5
0.2|0.5|0.4|27|VII(b) Hepatic carcinomas|73017204|0-19|All Races|Male and Female|2000|0.2|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|73017204|0-19|All Races|Male and Female|2000|~|~|~
7.9|9.2|8.5|624|VIII Malignant bone tumors|73017204|0-19|All Races|Male and Female|2000|7.9|9.2|8.5
4.4|5.4|4.8|355|VIII(a) Osteosarcomas|73017204|0-19|All Races|Male and Female|2000|4.4|5.4|4.9
~|~|~|~|VIII(b) Chondrosarcomas|73017204|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.5|3.1|225|VIII(c) Ewing tumor and related sarcomas of bone|73017204|0-19|All Races|Male and Female|2000|2.7|3.5|3.1
0.1|0.4|0.2|17|VIII(d) Other specified malignant bone tumors|73017204|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
~|~|~|~|VIII(e) Unspecified malignant bone tumors|73017204|0-19|All Races|Male and Female|2000|~|~|~
9.9|11.4|10.7|778|X Germ cell, trophoblastic tumors & neoplasms of gonads|73017204|0-19|All Races|Male and Female|2000|9.9|11.4|10.7
1.4|2.0|1.7|122|X(a) Intracranial & intraspinal germ cell tumors|73017204|0-19|All Races|Male and Female|2000|1.4|2.0|1.7
1.1|1.7|1.4|102|X(b) Malignant extracranial & extragonadal germ cell tumors|73017204|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.3|7.5|6.9|503|X(c) Malignant gonadal germ cell tumors|73017204|0-19|All Races|Male and Female|2000|6.3|7.5|6.9
0.3|0.7|0.5|35|X(d) Gonadal carcinomas|73017204|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
0.1|0.4|0.2|16|X(e) Other and unspecified malignant gonadal tumors|73017204|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
14.7|16.5|15.5|1136|XI Other malignant epithelial neoplasms and malignant melanomas|73017204|0-19|All Races|Male and Female|2000|14.7|16.5|15.6
0.2|0.5|0.3|23|XI(a) Adrenocortical carcinomas|73017204|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.1|6.2|5.7|414|XI(b) Thyroid carcinomas|73017204|0-19|All Races|Male and Female|2000|5.1|6.2|5.7
0.4|0.7|0.5|37|XI(c) Nasopharyngeal carcinomas|73017204|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.6|5.6|5.1|370|XI(d) Malignant melanomas|73017204|0-19|All Races|Male and Female|2000|4.6|5.6|5.1
~|~|~|~|XI(e) Skin carcinomas|73017204|0-19|All Races|Male and Female|2000|~|~|~
3.5|4.4|3.9|286|XI(f) Other and unspecified carcinomas|73017204|0-19|All Races|Male and Female|2000|3.5|4.4|3.9
0.5|0.9|0.7|48|XII Other and unspecified malignant neoplasms|73017204|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
~|~|~|~|XII(a) Other specified malignant tumors|73017204|0-19|All Races|Male and Female|2000|~|~|~
0.3|0.6|0.5|33|XII(b) Other unspecified malignant tumors|73017204|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
166.7|172.5|169.6|12981|All ICCC Groups Combined|76546373|0-19|All Races|Male and Female|2001|166.7|172.5|169.6
44.2|47.2|45.7|3483|I Leukemias, myeloproliferative & myelodysplastic diseases|76546373|0-19|All Races|Male and Female|2001|44.0|47.0|45.5
31.8|34.4|33.1|2520|I(a) Lymphoid leukemias|76546373|0-19|All Races|Male and Female|2001|31.6|34.2|32.9
7.1|8.3|7.7|589|I(b) Acute myeloid leukemias|76546373|0-19|All Races|Male and Female|2001|7.1|8.3|7.7
1.8|2.5|2.1|165|I(c) Chronic myeloproliferative diseases|76546373|0-19|All Races|Male and Female|2001|1.8|2.5|2.2
1.3|1.8|1.5|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76546373|0-19|All Races|Male and Female|2001|1.3|1.8|1.5
1.0|1.5|1.2|92|I(e) Unspecified and other specified leukemias|76546373|0-19|All Races|Male and Female|2001|1.0|1.5|1.2
23.6|25.8|24.7|1890|II Lymphomas and reticuloendothelial neoplasms|76546373|0-19|All Races|Male and Female|2001|23.6|25.8|24.7
11.8|13.4|12.6|964|II(a) Hodgkin lymphomas|76546373|0-19|All Races|Male and Female|2001|11.8|13.4|12.6
8.1|9.4|8.7|669|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76546373|0-19|All Races|Male and Female|2001|8.1|9.4|8.7
1.8|2.5|2.1|164|II(c) Burkitt lymphoma|76546373|0-19|All Races|Male and Female|2001|1.8|2.5|2.1
0.6|1.0|0.8|59|II(d) Miscellaneous lymphoreticular neoplasms|76546373|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.3|0.6|0.4|34|II(e) Unspecified lymphomas|76546373|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
28.3|30.7|29.5|2255|III CNS and misc intracranial and intraspinal neoplasms|76546373|0-19|All Races|Male and Female|2001|28.3|30.7|29.5
2.1|2.8|2.4|186|III(a) Ependymomas and choroid plexus tumor|76546373|0-19|All Races|Male and Female|2001|2.1|2.8|2.4
13.8|15.6|14.7|1121|III(b) Astrocytomas|76546373|0-19|All Races|Male and Female|2001|13.8|15.5|14.6
6.0|7.1|6.5|500|III(c) Intracranial and intraspinal embryonal tumors|76546373|0-19|All Races|Male and Female|2001|6.0|7.1|6.5
4.4|5.5|4.9|377|III(d) Other gliomas|76546373|0-19|All Races|Male and Female|2001|4.4|5.4|4.9
0.4|0.8|0.6|44|III(e) Other specified intracranial & intraspinal neoplasms|76546373|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
0.2|0.5|0.4|27|III(f) Unspecified intracranial and intraspinal neoplasms|76546373|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
8.2|9.6|8.9|684|IV Neuroblastoma and other peripheral nervous cell tumors|76546373|0-19|All Races|Male and Female|2001|8.3|9.6|8.9
8.1|9.4|8.7|671|IV(a) Neuroblastoma and ganglioneuroblastoma|76546373|0-19|All Races|Male and Female|2001|8.1|9.5|8.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|76546373|0-19|All Races|Male and Female|2001|~|~|~
10.9|12.5|11.7|895|IX Soft tissue and other extraosseous sarcomas|76546373|0-19|All Races|Male and Female|2001|10.9|12.5|11.7
4.4|5.4|4.9|374|IX(a) Rhabdomyosarcomas|76546373|0-19|All Races|Male and Female|2001|4.4|5.4|4.9
1.2|1.7|1.5|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76546373|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|76546373|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.0|311|IX(d) Other specified soft tissue sarcomas|76546373|0-19|All Races|Male and Female|2001|3.6|4.5|4.1
1.0|1.5|1.2|95|IX(e) Unspecified soft tissue sarcomas|76546373|0-19|All Races|Male and Female|2001|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|76546373|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
2.9|3.7|3.3|252|V Retinoblastoma|76546373|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
6.1|7.3|6.7|512|VI Renal tumors|76546373|0-19|All Races|Male and Female|2001|6.1|7.3|6.7
5.6|6.7|6.1|468|VI(a) Nephroblastoma and other nonepithelial renal tumors|76546373|0-19|All Races|Male and Female|2001|5.6|6.7|6.1
0.4|0.7|0.5|42|VI(b) Renal carcinomas|76546373|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|76546373|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.1|1.8|138|VII Hepatic tumors|76546373|0-19|All Races|Male and Female|2001|1.5|2.1|1.8
1.0|1.5|1.3|97|VII(a) Hepatoblastoma|76546373|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.4|0.7|0.5|40|VII(b) Hepatic carcinomas|76546373|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76546373|0-19|All Races|Male and Female|2001|~|~|~
8.7|10.1|9.4|723|VIII Malignant bone tumors|76546373|0-19|All Races|Male and Female|2001|8.8|10.2|9.4
4.6|5.6|5.1|393|VIII(a) Osteosarcomas|76546373|0-19|All Races|Male and Female|2001|4.6|5.7|5.1
0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|76546373|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
3.0|3.8|3.4|260|VIII(c) Ewing tumor and related sarcomas of bone|76546373|0-19|All Races|Male and Female|2001|3.0|3.8|3.4
0.3|0.6|0.4|31|VIII(d) Other specified malignant bone tumors|76546373|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|76546373|0-19|All Races|Male and Female|2001|~|~|~
9.7|11.2|10.4|802|X Germ cell, trophoblastic tumors & neoplasms of gonads|76546373|0-19|All Races|Male and Female|2001|9.8|11.2|10.5
1.3|1.9|1.6|121|X(a) Intracranial & intraspinal germ cell tumors|76546373|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|123|X(b) Malignant extracranial & extragonadal germ cell tumors|76546373|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
6.1|7.2|6.6|509|X(c) Malignant gonadal germ cell tumors|76546373|0-19|All Races|Male and Female|2001|6.1|7.3|6.6
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|76546373|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|23|X(e) Other and unspecified malignant gonadal tumors|76546373|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
15.7|17.5|16.6|1272|XI Other malignant epithelial neoplasms and malignant melanomas|76546373|0-19|All Races|Male and Female|2001|15.7|17.6|16.6
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|76546373|0-19|All Races|Male and Female|2001|0.1|0.3|0.2
5.3|6.4|5.8|449|XI(b) Thyroid carcinomas|76546373|0-19|All Races|Male and Female|2001|5.3|6.4|5.9
0.4|0.8|0.6|44|XI(c) Nasopharyngeal carcinomas|76546373|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
5.3|6.4|5.8|447|XI(d) Malignant melanomas|76546373|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
~|~|~|~|XI(e) Skin carcinomas|76546373|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.1|311|XI(f) Other and unspecified carcinomas|76546373|0-19|All Races|Male and Female|2001|3.6|4.5|4.1
0.5|0.9|0.7|53|XII Other and unspecified malignant neoplasms|76546373|0-19|All Races|Male and Female|2001|0.5|0.9|0.7
0.2|0.5|0.4|28|XII(a) Other specified malignant tumors|76546373|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
0.2|0.5|0.3|25|XII(b) Other unspecified malignant tumors|76546373|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
166.0|171.8|168.9|13298|All ICCC Groups Combined|78657753|0-19|All Races|Male and Female|2002|166.2|172.0|169.1
42.9|45.9|44.4|3488|I Leukemias, myeloproliferative & myelodysplastic diseases|78657753|0-19|All Races|Male and Female|2002|42.9|45.8|44.3
30.3|32.8|31.5|2474|I(a) Lymphoid leukemias|78657753|0-19|All Races|Male and Female|2002|30.2|32.7|31.5
7.5|8.8|8.2|644|I(b) Acute myeloid leukemias|78657753|0-19|All Races|Male and Female|2002|7.6|8.8|8.2
1.7|2.4|2.1|162|I(c) Chronic myeloproliferative diseases|78657753|0-19|All Races|Male and Female|2002|1.8|2.4|2.1
1.2|1.7|1.5|115|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78657753|0-19|All Races|Male and Female|2002|1.2|1.8|1.5
1.0|1.4|1.2|93|I(e) Unspecified and other specified leukemias|78657753|0-19|All Races|Male and Female|2002|1.0|1.4|1.2
23.2|25.4|24.3|1915|II Lymphomas and reticuloendothelial neoplasms|78657753|0-19|All Races|Male and Female|2002|23.3|25.5|24.3
11.5|13.1|12.3|970|II(a) Hodgkin lymphomas|78657753|0-19|All Races|Male and Female|2002|11.6|13.1|12.3
7.5|8.8|8.2|642|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78657753|0-19|All Races|Male and Female|2002|7.5|8.8|8.2
2.4|3.1|2.7|213|II(c) Burkitt lymphoma|78657753|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.6|1.1|0.8|66|II(d) Miscellaneous lymphoreticular neoplasms|78657753|0-19|All Races|Male and Female|2002|0.6|1.1|0.8
0.2|0.5|0.3|24|II(e) Unspecified lymphomas|78657753|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
29.5|31.9|30.7|2409|III CNS and misc intracranial and intraspinal neoplasms|78657753|0-19|All Races|Male and Female|2002|29.4|31.9|30.6
2.5|3.3|2.9|229|III(a) Ependymomas and choroid plexus tumor|78657753|0-19|All Races|Male and Female|2002|2.5|3.3|2.9
14.0|15.7|14.9|1167|III(b) Astrocytomas|78657753|0-19|All Races|Male and Female|2002|14.0|15.7|14.8
5.8|6.9|6.3|497|III(c) Intracranial and intraspinal embryonal tumors|78657753|0-19|All Races|Male and Female|2002|5.8|6.9|6.3
4.9|6.0|5.5|427|III(d) Other gliomas|78657753|0-19|All Races|Male and Female|2002|4.9|6.0|5.4
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|78657753|0-19|All Races|Male and Female|2002|0.5|0.9|0.7
0.3|0.6|0.4|32|III(f) Unspecified intracranial and intraspinal neoplasms|78657753|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
7.7|9.0|8.3|656|IV Neuroblastoma and other peripheral nervous cell tumors|78657753|0-19|All Races|Male and Female|2002|7.7|9.0|8.3
7.5|8.7|8.1|640|IV(a) Neuroblastoma and ganglioneuroblastoma|78657753|0-19|All Races|Male and Female|2002|7.5|8.8|8.1
0.1|0.3|0.2|16|IV(b) Other peripheral nervous cell tumors|78657753|0-19|All Races|Male and Female|2002|0.1|0.3|0.2
11.0|12.5|11.8|926|IX Soft tissue and other extraosseous sarcomas|78657753|0-19|All Races|Male and Female|2002|11.0|12.6|11.8
4.3|5.3|4.8|377|IX(a) Rhabdomyosarcomas|78657753|0-19|All Races|Male and Female|2002|4.3|5.3|4.8
0.9|1.4|1.2|92|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78657753|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|78657753|0-19|All Races|Male and Female|2002|~|~|~
4.4|5.3|4.8|381|IX(d) Other specified soft tissue sarcomas|78657753|0-19|All Races|Male and Female|2002|4.4|5.4|4.8
0.8|1.2|1.0|76|IX(e) Unspecified soft tissue sarcomas|78657753|0-19|All Races|Male and Female|2002|0.8|1.2|1.0
0.2|0.5|0.4|29|Not classified by ICCC|78657753|0-19|All Races|Male and Female|2002|0.2|0.5|0.4
2.4|3.2|2.8|219|V Retinoblastoma|78657753|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
5.9|7.0|6.5|507|VI Renal tumors|78657753|0-19|All Races|Male and Female|2002|5.9|7.0|6.4
5.5|6.6|6.0|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|78657753|0-19|All Races|Male and Female|2002|5.5|6.6|6.0
0.3|0.6|0.4|34|VI(b) Renal carcinomas|78657753|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
~|~|~|~|VI(c) Unspecified malignant renal tumors|78657753|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|132|VII Hepatic tumors|78657753|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
0.9|1.4|1.2|92|VII(a) Hepatoblastoma|78657753|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
0.4|0.7|0.5|39|VII(b) Hepatic carcinomas|78657753|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78657753|0-19|All Races|Male and Female|2002|~|~|~
8.5|9.9|9.2|724|VIII Malignant bone tumors|78657753|0-19|All Races|Male and Female|2002|8.5|9.9|9.2
4.5|5.5|4.9|391|VIII(a) Osteosarcomas|78657753|0-19|All Races|Male and Female|2002|4.5|5.5|5.0
0.3|0.7|0.5|38|VIII(b) Chondrosarcomas|78657753|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
2.7|3.5|3.1|243|VIII(c) Ewing tumor and related sarcomas of bone|78657753|0-19|All Races|Male and Female|2002|2.7|3.5|3.1
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|78657753|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|78657753|0-19|All Races|Male and Female|2002|~|~|~
10.3|11.8|11.1|874|X Germ cell, trophoblastic tumors & neoplasms of gonads|78657753|0-19|All Races|Male and Female|2002|10.4|11.9|11.1
1.4|2.0|1.6|130|X(a) Intracranial & intraspinal germ cell tumors|78657753|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
1.3|1.9|1.6|125|X(b) Malignant extracranial & extragonadal germ cell tumors|78657753|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.7|7.9|7.3|572|X(c) Malignant gonadal germ cell tumors|78657753|0-19|All Races|Male and Female|2002|6.7|7.9|7.3
0.2|0.5|0.3|25|X(d) Gonadal carcinomas|78657753|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
0.2|0.4|0.3|22|X(e) Other and unspecified malignant gonadal tumors|78657753|0-19|All Races|Male and Female|2002|0.2|0.4|0.3
16.3|18.2|17.2|1360|XI Other malignant epithelial neoplasms and malignant melanomas|78657753|0-19|All Races|Male and Female|2002|16.4|18.2|17.3
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|78657753|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
5.2|6.3|5.7|451|XI(b) Thyroid carcinomas|78657753|0-19|All Races|Male and Female|2002|5.2|6.3|5.7
0.5|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|78657753|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
6.0|7.1|6.5|513|XI(d) Malignant melanomas|78657753|0-19|All Races|Male and Female|2002|6.0|7.1|6.5
~|~|~|~|XI(e) Skin carcinomas|78657753|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.1|320|XI(f) Other and unspecified carcinomas|78657753|0-19|All Races|Male and Female|2002|3.6|4.5|4.1
0.6|1.0|0.7|59|XII Other and unspecified malignant neoplasms|78657753|0-19|All Races|Male and Female|2002|0.6|1.0|0.8
0.3|0.6|0.4|35|XII(a) Other specified malignant tumors|78657753|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
0.2|0.5|0.3|24|XII(b) Other unspecified malignant tumors|78657753|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
163.0|168.6|165.7|13553|All ICCC Groups Combined|81485313|0-19|All Races|Male and Female|2003|163.5|169.1|166.3
41.4|44.2|42.8|3490|I Leukemias, myeloproliferative & myelodysplastic diseases|81485313|0-19|All Races|Male and Female|2003|41.4|44.3|42.8
29.2|31.6|30.3|2470|I(a) Lymphoid leukemias|81485313|0-19|All Races|Male and Female|2003|29.1|31.5|30.3
7.1|8.3|7.7|630|I(b) Acute myeloid leukemias|81485313|0-19|All Races|Male and Female|2003|7.1|8.4|7.7
1.8|2.5|2.1|173|I(c) Chronic myeloproliferative diseases|81485313|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.4|1.9|1.6|135|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81485313|0-19|All Races|Male and Female|2003|1.4|2.0|1.7
0.8|1.2|1.0|82|I(e) Unspecified and other specified leukemias|81485313|0-19|All Races|Male and Female|2003|0.8|1.2|1.0
23.1|25.2|24.2|1973|II Lymphomas and reticuloendothelial neoplasms|81485313|0-19|All Races|Male and Female|2003|23.2|25.3|24.2
11.7|13.3|12.5|1021|II(a) Hodgkin lymphomas|81485313|0-19|All Races|Male and Female|2003|11.8|13.3|12.5
7.4|8.7|8.0|655|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81485313|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
2.3|3.0|2.6|211|II(c) Burkitt lymphoma|81485313|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.6|1.0|0.8|68|II(d) Miscellaneous lymphoreticular neoplasms|81485313|0-19|All Races|Male and Female|2003|0.6|1.1|0.8
0.1|0.3|0.2|18|II(e) Unspecified lymphomas|81485313|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
28.4|30.8|29.5|2406|III CNS and misc intracranial and intraspinal neoplasms|81485313|0-19|All Races|Male and Female|2003|28.4|30.7|29.5
2.0|2.7|2.3|188|III(a) Ependymomas and choroid plexus tumor|81485313|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
14.2|15.8|15.0|1221|III(b) Astrocytomas|81485313|0-19|All Races|Male and Female|2003|14.2|15.8|15.0
5.5|6.6|6.0|491|III(c) Intracranial and intraspinal embryonal tumors|81485313|0-19|All Races|Male and Female|2003|5.5|6.6|6.0
4.6|5.6|5.1|414|III(d) Other gliomas|81485313|0-19|All Races|Male and Female|2003|4.6|5.6|5.1
0.6|1.0|0.8|62|III(e) Other specified intracranial & intraspinal neoplasms|81485313|0-19|All Races|Male and Female|2003|0.6|1.0|0.8
0.2|0.5|0.4|30|III(f) Unspecified intracranial and intraspinal neoplasms|81485313|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
7.5|8.7|8.1|667|IV Neuroblastoma and other peripheral nervous cell tumors|81485313|0-19|All Races|Male and Female|2003|7.6|8.8|8.2
7.3|8.5|7.9|654|IV(a) Neuroblastoma and ganglioneuroblastoma|81485313|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|81485313|0-19|All Races|Male and Female|2003|~|~|~
11.3|12.8|12.0|983|IX Soft tissue and other extraosseous sarcomas|81485313|0-19|All Races|Male and Female|2003|11.3|12.8|12.1
4.3|5.3|4.8|392|IX(a) Rhabdomyosarcomas|81485313|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.1|1.7|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81485313|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81485313|0-19|All Races|Male and Female|2003|~|~|~
4.1|5.0|4.6|374|IX(d) Other specified soft tissue sarcomas|81485313|0-19|All Races|Male and Female|2003|4.1|5.1|4.6
1.0|1.5|1.2|100|IX(e) Unspecified soft tissue sarcomas|81485313|0-19|All Races|Male and Female|2003|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|81485313|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.6|3.4|3.0|246|V Retinoblastoma|81485313|0-19|All Races|Male and Female|2003|2.7|3.4|3.0
6.1|7.2|6.6|542|VI Renal tumors|81485313|0-19|All Races|Male and Female|2003|6.1|7.2|6.7
5.5|6.6|6.0|493|VI(a) Nephroblastoma and other nonepithelial renal tumors|81485313|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
0.4|0.7|0.6|45|VI(b) Renal carcinomas|81485313|0-19|All Races|Male and Female|2003|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81485313|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.4|2.1|173|VII Hepatic tumors|81485313|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.2|1.8|1.5|124|VII(a) Hepatoblastoma|81485313|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81485313|0-19|All Races|Male and Female|2003|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81485313|0-19|All Races|Male and Female|2003|~|~|~
8.1|9.4|8.7|712|VIII Malignant bone tumors|81485313|0-19|All Races|Male and Female|2003|8.1|9.4|8.7
4.8|5.9|5.3|437|VIII(a) Osteosarcomas|81485313|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81485313|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.2|2.9|2.6|210|VIII(c) Ewing tumor and related sarcomas of bone|81485313|0-19|All Races|Male and Female|2003|2.2|3.0|2.6
0.2|0.5|0.3|27|VIII(d) Other specified malignant bone tumors|81485313|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81485313|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.6|11.0|10.2|841|X Germ cell, trophoblastic tumors & neoplasms of gonads|81485313|0-19|All Races|Male and Female|2003|9.6|11.0|10.3
1.1|1.6|1.4|112|X(a) Intracranial & intraspinal germ cell tumors|81485313|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.7|1.4|119|X(b) Malignant extracranial & extragonadal germ cell tumors|81485313|0-19|All Races|Male and Female|2003|1.2|1.7|1.5
6.2|7.3|6.7|550|X(c) Malignant gonadal germ cell tumors|81485313|0-19|All Races|Male and Female|2003|6.2|7.3|6.7
0.2|0.5|0.4|29|X(d) Gonadal carcinomas|81485313|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
0.3|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|81485313|0-19|All Races|Male and Female|2003|0.3|0.5|0.4
16.4|18.2|17.3|1416|XI Other malignant epithelial neoplasms and malignant melanomas|81485313|0-19|All Races|Male and Female|2003|16.5|18.3|17.4
0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|81485313|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
5.6|6.7|6.2|505|XI(b) Thyroid carcinomas|81485313|0-19|All Races|Male and Female|2003|5.7|6.8|6.2
0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81485313|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.4|6.5|5.9|486|XI(d) Malignant melanomas|81485313|0-19|All Races|Male and Female|2003|5.4|6.5|6.0
~|~|~|~|XI(e) Skin carcinomas|81485313|0-19|All Races|Male and Female|2003|~|~|~
3.7|4.6|4.2|341|XI(f) Other and unspecified carcinomas|81485313|0-19|All Races|Male and Female|2003|3.8|4.7|4.2
0.8|1.2|1.0|82|XII Other and unspecified malignant neoplasms|81485313|0-19|All Races|Male and Female|2003|0.8|1.2|1.0
0.3|0.6|0.5|38|XII(a) Other specified malignant tumors|81485313|0-19|All Races|Male and Female|2003|0.3|0.6|0.5
0.4|0.7|0.5|44|XII(b) Other unspecified malignant tumors|81485313|0-19|All Races|Male and Female|2003|0.4|0.7|0.5
169.6|175.3|172.4|14190|All ICCC Groups Combined|81819970|0-19|All Races|Male and Female|2004|170.6|176.3|173.4
44.0|46.9|45.5|3734|I Leukemias, myeloproliferative & myelodysplastic diseases|81819970|0-19|All Races|Male and Female|2004|44.2|47.1|45.6
31.5|33.9|32.7|2680|I(a) Lymphoid leukemias|81819970|0-19|All Races|Male and Female|2004|31.5|34.0|32.8
7.6|8.8|8.2|675|I(b) Acute myeloid leukemias|81819970|0-19|All Races|Male and Female|2004|7.6|8.9|8.2
1.7|2.3|2.0|162|I(c) Chronic myeloproliferative diseases|81819970|0-19|All Races|Male and Female|2004|1.7|2.3|2.0
1.1|1.6|1.4|112|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81819970|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
1.0|1.5|1.3|105|I(e) Unspecified and other specified leukemias|81819970|0-19|All Races|Male and Female|2004|1.0|1.6|1.3
23.3|25.4|24.3|2000|II Lymphomas and reticuloendothelial neoplasms|81819970|0-19|All Races|Male and Female|2004|23.4|25.5|24.4
11.3|12.8|12.0|991|II(a) Hodgkin lymphomas|81819970|0-19|All Races|Male and Female|2004|11.4|12.9|12.1
7.9|9.2|8.6|703|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81819970|0-19|All Races|Male and Female|2004|8.0|9.3|8.6
2.0|2.7|2.4|192|II(c) Burkitt lymphoma|81819970|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.8|1.2|1.0|83|II(d) Miscellaneous lymphoreticular neoplasms|81819970|0-19|All Races|Male and Female|2004|0.8|1.3|1.0
0.3|0.5|0.4|31|II(e) Unspecified lymphomas|81819970|0-19|All Races|Male and Female|2004|0.3|0.5|0.4
30.0|32.4|31.2|2547|III CNS and misc intracranial and intraspinal neoplasms|81819970|0-19|All Races|Male and Female|2004|29.9|32.4|31.1
2.4|3.1|2.7|222|III(a) Ependymomas and choroid plexus tumor|81819970|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
15.0|16.7|15.8|1292|III(b) Astrocytomas|81819970|0-19|All Races|Male and Female|2004|14.9|16.7|15.8
6.0|7.1|6.5|531|III(c) Intracranial and intraspinal embryonal tumors|81819970|0-19|All Races|Male and Female|2004|5.9|7.1|6.5
4.5|5.5|5.0|406|III(d) Other gliomas|81819970|0-19|All Races|Male and Female|2004|4.5|5.5|5.0
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|81819970|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.3|0.6|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|81819970|0-19|All Races|Male and Female|2004|0.3|0.7|0.5
7.7|8.9|8.3|690|IV Neuroblastoma and other peripheral nervous cell tumors|81819970|0-19|All Races|Male and Female|2004|7.8|9.1|8.4
7.4|8.6|8.0|668|IV(a) Neuroblastoma and ganglioneuroblastoma|81819970|0-19|All Races|Male and Female|2004|7.6|8.8|8.2
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|81819970|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.8|12.0|989|IX Soft tissue and other extraosseous sarcomas|81819970|0-19|All Races|Male and Female|2004|11.3|12.9|12.1
3.9|4.8|4.3|357|IX(a) Rhabdomyosarcomas|81819970|0-19|All Races|Male and Female|2004|3.9|4.8|4.4
1.1|1.6|1.4|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81819970|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81819970|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|416|IX(d) Other specified soft tissue sarcomas|81819970|0-19|All Races|Male and Female|2004|4.6|5.6|5.1
1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|81819970|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.5|0.3|28|Not classified by ICCC|81819970|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
2.8|3.6|3.1|265|V Retinoblastoma|81819970|0-19|All Races|Male and Female|2004|2.9|3.7|3.2
5.8|6.9|6.4|526|VI Renal tumors|81819970|0-19|All Races|Male and Female|2004|5.9|7.0|6.4
5.3|6.3|5.8|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|81819970|0-19|All Races|Male and Female|2004|5.3|6.4|5.9
0.4|0.7|0.6|46|VI(b) Renal carcinomas|81819970|0-19|All Races|Male and Female|2004|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81819970|0-19|All Races|Male and Female|2004|~|~|~
2.0|2.7|2.4|197|VII Hepatic tumors|81819970|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.4|2.0|1.7|143|VII(a) Hepatoblastoma|81819970|0-19|All Races|Male and Female|2004|1.5|2.1|1.7
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81819970|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81819970|0-19|All Races|Male and Female|2004|~|~|~
8.4|9.7|9.0|741|VIII Malignant bone tumors|81819970|0-19|All Races|Male and Female|2004|8.4|9.7|9.1
4.7|5.7|5.2|423|VIII(a) Osteosarcomas|81819970|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|41|VIII(b) Chondrosarcomas|81819970|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.4|3.1|2.7|225|VIII(c) Ewing tumor and related sarcomas of bone|81819970|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
0.3|0.6|0.5|39|VIII(d) Other specified malignant bone tumors|81819970|0-19|All Races|Male and Female|2004|0.3|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81819970|0-19|All Races|Male and Female|2004|~|~|~
10.4|11.9|11.1|921|X Germ cell, trophoblastic tumors & neoplasms of gonads|81819970|0-19|All Races|Male and Female|2004|10.5|12.0|11.3
1.5|2.1|1.8|148|X(a) Intracranial & intraspinal germ cell tumors|81819970|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|81819970|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
6.8|7.9|7.3|606|X(c) Malignant gonadal germ cell tumors|81819970|0-19|All Races|Male and Female|2004|6.8|8.0|7.4
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|81819970|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|26|X(e) Other and unspecified malignant gonadal tumors|81819970|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
17.1|19.0|18.0|1486|XI Other malignant epithelial neoplasms and malignant melanomas|81819970|0-19|All Races|Male and Female|2004|17.3|19.1|18.2
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81819970|0-19|All Races|Male and Female|2004|0.1|0.4|0.2
6.3|7.4|6.8|562|XI(b) Thyroid carcinomas|81819970|0-19|All Races|Male and Female|2004|6.3|7.5|6.9
0.4|0.8|0.6|47|XI(c) Nasopharyngeal carcinomas|81819970|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
5.9|7.1|6.5|535|XI(d) Malignant melanomas|81819970|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
~|~|~|~|XI(e) Skin carcinomas|81819970|0-19|All Races|Male and Female|2004|~|~|~
3.4|4.3|3.8|315|XI(f) Other and unspecified carcinomas|81819970|0-19|All Races|Male and Female|2004|3.4|4.3|3.8
0.6|1.0|0.8|66|XII Other and unspecified malignant neoplasms|81819970|0-19|All Races|Male and Female|2004|0.6|1.0|0.8
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|81819970|0-19|All Races|Male and Female|2004|0.2|0.5|0.4
0.3|0.6|0.4|36|XII(b) Other unspecified malignant tumors|81819970|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
169.7|172.2|170.9|71140|All ICCC Groups Combined|412337089|0-19|All Races|Male and Female|2004-2008|171.3|173.8|172.5
44.7|46.0|45.3|18833|I Leukemias, myeloproliferative & myelodysplastic diseases|412337089|0-19|All Races|Male and Female|2004-2008|45.0|46.3|45.7
32.0|33.1|32.5|13506|I(a) Lymphoid leukemias|412337089|0-19|All Races|Male and Female|2004-2008|32.2|33.3|32.8
7.6|8.2|7.9|3293|I(b) Acute myeloid leukemias|412337089|0-19|All Races|Male and Female|2004-2008|7.7|8.3|8.0
2.0|2.3|2.2|898|I(c) Chronic myeloproliferative diseases|412337089|0-19|All Races|Male and Female|2004-2008|2.0|2.3|2.2
1.3|1.6|1.5|609|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|412337089|0-19|All Races|Male and Female|2004-2008|1.4|1.6|1.5
1.2|1.4|1.3|527|I(e) Unspecified and other specified leukemias|412337089|0-19|All Races|Male and Female|2004-2008|1.2|1.4|1.3
24.6|25.6|25.1|10395|II Lymphomas and reticuloendothelial neoplasms|412337089|0-19|All Races|Male and Female|2004-2008|24.7|25.7|25.2
12.2|12.9|12.5|5220|II(a) Hodgkin lymphomas|412337089|0-19|All Races|Male and Female|2004-2008|12.3|13.0|12.7
8.4|9.0|8.7|3593|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|412337089|0-19|All Races|Male and Female|2004-2008|8.4|9.0|8.7
2.3|2.6|2.5|1012|II(c) Burkitt lymphoma|412337089|0-19|All Races|Male and Female|2004-2008|2.3|2.6|2.5
0.9|1.1|1.0|426|II(d) Miscellaneous lymphoreticular neoplasms|412337089|0-19|All Races|Male and Female|2004-2008|0.9|1.1|1.0
0.3|0.4|0.3|144|II(e) Unspecified lymphomas|412337089|0-19|All Races|Male and Female|2004-2008|0.3|0.4|0.3
29.5|30.6|30.1|12410|III CNS and misc intracranial and intraspinal neoplasms|412337089|0-19|All Races|Male and Female|2004-2008|29.6|30.6|30.1
2.4|2.8|2.6|1079|III(a) Ependymomas and choroid plexus tumor|412337089|0-19|All Races|Male and Female|2004-2008|2.5|2.8|2.6
14.6|15.4|15.0|6183|III(b) Astrocytomas|412337089|0-19|All Races|Male and Female|2004-2008|14.6|15.4|15.0
6.0|6.5|6.2|2582|III(c) Intracranial and intraspinal embryonal tumors|412337089|0-19|All Races|Male and Female|2004-2008|6.0|6.5|6.3
4.9|5.3|5.1|2088|III(d) Other gliomas|412337089|0-19|All Races|Male and Female|2004-2008|4.8|5.3|5.1
0.6|0.7|0.7|271|III(e) Other specified intracranial & intraspinal neoplasms|412337089|0-19|All Races|Male and Female|2004-2008|0.6|0.7|0.7
0.4|0.6|0.5|207|III(f) Unspecified intracranial and intraspinal neoplasms|412337089|0-19|All Races|Male and Female|2004-2008|0.4|0.6|0.5
7.9|8.4|8.1|3463|IV Neuroblastoma and other peripheral nervous cell tumors|412337089|0-19|All Races|Male and Female|2004-2008|8.1|8.7|8.4
7.7|8.2|7.9|3378|IV(a) Neuroblastoma and ganglioneuroblastoma|412337089|0-19|All Races|Male and Female|2004-2008|7.9|8.5|8.2
0.2|0.3|0.2|85|IV(b) Other peripheral nervous cell tumors|412337089|0-19|All Races|Male and Female|2004-2008|0.2|0.3|0.2
11.7|12.3|12.0|4972|IX Soft tissue and other extraosseous sarcomas|412337089|0-19|All Races|Male and Female|2004-2008|11.7|12.4|12.1
4.5|4.9|4.7|1960|IX(a) Rhabdomyosarcomas|412337089|0-19|All Races|Male and Female|2004-2008|4.5|5.0|4.8
1.2|1.4|1.3|530|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|412337089|0-19|All Races|Male and Female|2004-2008|1.2|1.4|1.3
~|~|~|~|IX(c) Kaposi sarcoma|412337089|0-19|All Races|Male and Female|2004-2008|~|~|~
4.5|4.9|4.7|1962|IX(d) Other specified soft tissue sarcomas|412337089|0-19|All Races|Male and Female|2004-2008|4.6|5.0|4.8
1.1|1.3|1.2|505|IX(e) Unspecified soft tissue sarcomas|412337089|0-19|All Races|Male and Female|2004-2008|1.1|1.3|1.2
0.3|0.4|0.3|129|Not classified by ICCC|412337089|0-19|All Races|Male and Female|2004-2008|0.3|0.4|0.3
2.8|3.1|3.0|1269|V Retinoblastoma|412337089|0-19|All Races|Male and Female|2004-2008|2.9|3.3|3.1
6.3|6.8|6.6|2766|VI Renal tumors|412337089|0-19|All Races|Male and Female|2004-2008|6.5|7.0|6.7
5.7|6.1|5.9|2482|VI(a) Nephroblastoma and other nonepithelial renal tumors|412337089|0-19|All Races|Male and Female|2004-2008|5.8|6.3|6.0
0.6|0.7|0.6|268|VI(b) Renal carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|0.6|0.7|0.6
0.0|0.1|0.0|16|VI(c) Unspecified malignant renal tumors|412337089|0-19|All Races|Male and Female|2004-2008|0.0|0.1|0.0
2.1|2.3|2.2|935|VII Hepatic tumors|412337089|0-19|All Races|Male and Female|2004-2008|2.1|2.4|2.3
1.5|1.7|1.6|678|VII(a) Hepatoblastoma|412337089|0-19|All Races|Male and Female|2004-2008|1.5|1.8|1.6
0.5|0.7|0.6|244|VII(b) Hepatic carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|0.5|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|412337089|0-19|All Races|Male and Female|2004-2008|~|~|~
8.6|9.2|8.9|3658|VIII Malignant bone tumors|412337089|0-19|All Races|Male and Female|2004-2008|8.6|9.2|8.9
4.8|5.3|5.0|2071|VIII(a) Osteosarcomas|412337089|0-19|All Races|Male and Female|2004-2008|4.8|5.2|5.0
0.3|0.4|0.3|143|VIII(b) Chondrosarcomas|412337089|0-19|All Races|Male and Female|2004-2008|0.3|0.4|0.3
2.7|3.1|2.9|1188|VIII(c) Ewing tumor and related sarcomas of bone|412337089|0-19|All Races|Male and Female|2004-2008|2.7|3.0|2.9
0.4|0.5|0.4|171|VIII(d) Other specified malignant bone tumors|412337089|0-19|All Races|Male and Female|2004-2008|0.4|0.5|0.4
0.2|0.3|0.2|85|VIII(e) Unspecified malignant bone tumors|412337089|0-19|All Races|Male and Female|2004-2008|0.2|0.3|0.2
10.6|11.2|10.9|4587|X Germ cell, trophoblastic tumors & neoplasms of gonads|412337089|0-19|All Races|Male and Female|2004-2008|10.8|11.5|11.1
1.5|1.8|1.6|675|X(a) Intracranial & intraspinal germ cell tumors|412337089|0-19|All Races|Male and Female|2004-2008|1.5|1.8|1.6
1.3|1.5|1.4|601|X(b) Malignant extracranial & extragonadal germ cell tumors|412337089|0-19|All Races|Male and Female|2004-2008|1.3|1.6|1.5
7.0|7.5|7.2|3035|X(c) Malignant gonadal germ cell tumors|412337089|0-19|All Races|Male and Female|2004-2008|7.1|7.6|7.4
0.3|0.5|0.4|163|X(d) Gonadal carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|0.3|0.5|0.4
0.2|0.3|0.3|113|X(e) Other and unspecified malignant gonadal tumors|412337089|0-19|All Races|Male and Female|2004-2008|0.2|0.3|0.3
17.3|18.1|17.7|7387|XI Other malignant epithelial neoplasms and malignant melanomas|412337089|0-19|All Races|Male and Female|2004-2008|17.5|18.3|17.9
0.2|0.2|0.2|80|XI(a) Adrenocortical carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|0.2|0.2|0.2
6.7|7.2|7.0|2908|XI(b) Thyroid carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|6.8|7.3|7.1
0.5|0.6|0.6|232|XI(c) Nasopharyngeal carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|0.5|0.6|0.6
5.5|6.0|5.7|2403|XI(d) Malignant melanomas|412337089|0-19|All Races|Male and Female|2004-2008|5.6|6.1|5.8
0.1|0.1|0.1|33|XI(e) Skin carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|0.1|0.1|0.1
4.0|4.3|4.1|1731|XI(f) Other and unspecified carcinomas|412337089|0-19|All Races|Male and Female|2004-2008|4.0|4.4|4.2
0.7|0.9|0.8|336|XII Other and unspecified malignant neoplasms|412337089|0-19|All Races|Male and Female|2004-2008|0.7|0.9|0.8
0.3|0.4|0.4|159|XII(a) Other specified malignant tumors|412337089|0-19|All Races|Male and Female|2004-2008|0.3|0.5|0.4
0.4|0.5|0.4|177|XII(b) Other unspecified malignant tumors|412337089|0-19|All Races|Male and Female|2004-2008|0.4|0.5|0.4
167.3|172.9|170.1|14080|All ICCC Groups Combined|82072745|0-19|All Races|Male and Female|2005|168.7|174.4|171.6
42.4|45.3|43.9|3623|I Leukemias, myeloproliferative & myelodysplastic diseases|82072745|0-19|All Races|Male and Female|2005|42.7|45.6|44.1
30.5|32.9|31.7|2614|I(a) Lymphoid leukemias|82072745|0-19|All Races|Male and Female|2005|30.6|33.1|31.8
6.9|8.1|7.5|622|I(b) Acute myeloid leukemias|82072745|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.6|2.2|1.9|154|I(c) Chronic myeloproliferative diseases|82072745|0-19|All Races|Male and Female|2005|1.6|2.2|1.9
1.3|1.8|1.5|126|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82072745|0-19|All Races|Male and Female|2005|1.3|1.8|1.5
1.1|1.6|1.3|107|I(e) Unspecified and other specified leukemias|82072745|0-19|All Races|Male and Female|2005|1.1|1.6|1.3
24.9|27.1|26.0|2146|II Lymphomas and reticuloendothelial neoplasms|82072745|0-19|All Races|Male and Female|2005|25.1|27.3|26.1
12.2|13.8|13.0|1075|II(a) Hodgkin lymphomas|82072745|0-19|All Races|Male and Female|2005|12.3|13.9|13.1
8.4|9.7|9.0|743|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82072745|0-19|All Races|Male and Female|2005|8.4|9.7|9.1
2.2|2.9|2.5|204|II(c) Burkitt lymphoma|82072745|0-19|All Races|Male and Female|2005|2.2|2.9|2.5
0.9|1.4|1.2|97|II(d) Miscellaneous lymphoreticular neoplasms|82072745|0-19|All Races|Male and Female|2005|1.0|1.4|1.2
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|82072745|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
27.9|30.2|29.0|2380|III CNS and misc intracranial and intraspinal neoplasms|82072745|0-19|All Races|Male and Female|2005|27.8|30.2|29.0
2.5|3.3|2.9|237|III(a) Ependymomas and choroid plexus tumor|82072745|0-19|All Races|Male and Female|2005|2.5|3.3|2.9
13.9|15.5|14.7|1204|III(b) Astrocytomas|82072745|0-19|All Races|Male and Female|2005|13.9|15.5|14.7
5.2|6.3|5.7|471|III(c) Intracranial and intraspinal embryonal tumors|82072745|0-19|All Races|Male and Female|2005|5.2|6.3|5.7
4.2|5.1|4.6|379|III(d) Other gliomas|82072745|0-19|All Races|Male and Female|2005|4.2|5.1|4.6
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|82072745|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82072745|0-19|All Races|Male and Female|2005|0.3|0.6|0.5
8.2|9.4|8.8|739|IV Neuroblastoma and other peripheral nervous cell tumors|82072745|0-19|All Races|Male and Female|2005|8.4|9.7|9.0
8.0|9.2|8.6|722|IV(a) Neuroblastoma and ganglioneuroblastoma|82072745|0-19|All Races|Male and Female|2005|8.2|9.5|8.8
0.1|0.3|0.2|17|IV(b) Other peripheral nervous cell tumors|82072745|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
11.5|13.1|12.3|1012|IX Soft tissue and other extraosseous sarcomas|82072745|0-19|All Races|Male and Female|2005|11.6|13.1|12.3
4.4|5.4|4.9|399|IX(a) Rhabdomyosarcomas|82072745|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
1.1|1.7|1.4|115|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82072745|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82072745|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|406|IX(d) Other specified soft tissue sarcomas|82072745|0-19|All Races|Male and Female|2005|4.5|5.5|4.9
0.9|1.3|1.1|88|IX(e) Unspecified soft tissue sarcomas|82072745|0-19|All Races|Male and Female|2005|0.9|1.3|1.1
0.2|0.5|0.3|28|Not classified by ICCC|82072745|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
2.5|3.2|2.8|240|V Retinoblastoma|82072745|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
6.0|7.1|6.6|547|VI Renal tumors|82072745|0-19|All Races|Male and Female|2005|6.1|7.2|6.7
5.4|6.4|5.9|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|82072745|0-19|All Races|Male and Female|2005|5.5|6.5|6.0
0.5|0.8|0.6|51|VI(b) Renal carcinomas|82072745|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82072745|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.3|2.0|165|VII Hepatic tumors|82072745|0-19|All Races|Male and Female|2005|1.7|2.3|2.0
1.1|1.6|1.4|116|VII(a) Hepatoblastoma|82072745|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.8|0.6|47|VII(b) Hepatic carcinomas|82072745|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82072745|0-19|All Races|Male and Female|2005|~|~|~
8.2|9.5|8.8|727|VIII Malignant bone tumors|82072745|0-19|All Races|Male and Female|2005|8.2|9.5|8.9
4.6|5.5|5.0|413|VIII(a) Osteosarcomas|82072745|0-19|All Races|Male and Female|2005|4.6|5.5|5.0
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|82072745|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|241|VIII(c) Ewing tumor and related sarcomas of bone|82072745|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82072745|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|82072745|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
10.7|12.1|11.4|951|X Germ cell, trophoblastic tumors & neoplasms of gonads|82072745|0-19|All Races|Male and Female|2005|10.9|12.3|11.6
1.3|1.9|1.6|129|X(a) Intracranial & intraspinal germ cell tumors|82072745|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.3|1.8|1.6|132|X(b) Malignant extracranial & extragonadal germ cell tumors|82072745|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
7.0|8.2|7.6|632|X(c) Malignant gonadal germ cell tumors|82072745|0-19|All Races|Male and Female|2005|7.1|8.3|7.7
0.3|0.5|0.4|31|X(d) Gonadal carcinomas|82072745|0-19|All Races|Male and Female|2005|0.3|0.5|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|82072745|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.5|18.4|17.4|1450|XI Other malignant epithelial neoplasms and malignant melanomas|82072745|0-19|All Races|Male and Female|2005|16.8|18.6|17.7
~|~|~|~|XI(a) Adrenocortical carcinomas|82072745|0-19|All Races|Male and Female|2005|~|~|~
5.5|6.6|6.1|504|XI(b) Thyroid carcinomas|82072745|0-19|All Races|Male and Female|2005|5.6|6.7|6.1
0.3|0.6|0.4|33|XI(c) Nasopharyngeal carcinomas|82072745|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.5|543|XI(d) Malignant melanomas|82072745|0-19|All Races|Male and Female|2005|6.1|7.2|6.6
~|~|~|~|XI(e) Skin carcinomas|82072745|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.7|4.2|351|XI(f) Other and unspecified carcinomas|82072745|0-19|All Races|Male and Female|2005|3.8|4.7|4.3
0.7|1.1|0.9|72|XII Other and unspecified malignant neoplasms|82072745|0-19|All Races|Male and Female|2005|0.7|1.1|0.9
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|82072745|0-19|All Races|Male and Female|2005|0.2|0.5|0.4
0.4|0.7|0.5|42|XII(b) Other unspecified malignant tumors|82072745|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
166.6|172.2|169.4|14089|All ICCC Groups Combined|82389800|0-19|All Races|Male and Female|2006|168.2|173.9|171.0
44.2|47.2|45.7|3791|I Leukemias, myeloproliferative & myelodysplastic diseases|82389800|0-19|All Races|Male and Female|2006|44.6|47.5|46.0
31.3|33.8|32.5|2695|I(a) Lymphoid leukemias|82389800|0-19|All Races|Male and Female|2006|31.5|34.0|32.7
7.4|8.6|8.0|668|I(b) Acute myeloid leukemias|82389800|0-19|All Races|Male and Female|2006|7.5|8.7|8.1
1.9|2.5|2.2|180|I(c) Chronic myeloproliferative diseases|82389800|0-19|All Races|Male and Female|2006|1.9|2.5|2.2
1.3|1.9|1.6|131|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82389800|0-19|All Races|Male and Female|2006|1.3|1.9|1.6
1.2|1.7|1.4|117|I(e) Unspecified and other specified leukemias|82389800|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
23.9|26.1|25.0|2075|II Lymphomas and reticuloendothelial neoplasms|82389800|0-19|All Races|Male and Female|2006|24.1|26.3|25.2
11.9|13.4|12.6|1053|II(a) Hodgkin lymphomas|82389800|0-19|All Races|Male and Female|2006|12.0|13.6|12.8
8.0|9.3|8.6|713|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82389800|0-19|All Races|Male and Female|2006|8.0|9.3|8.7
2.1|2.7|2.4|195|II(c) Burkitt lymphoma|82389800|0-19|All Races|Male and Female|2006|2.0|2.7|2.4
0.9|1.3|1.1|91|II(d) Miscellaneous lymphoreticular neoplasms|82389800|0-19|All Races|Male and Female|2006|0.9|1.4|1.1
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82389800|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
28.8|31.2|30.0|2471|III CNS and misc intracranial and intraspinal neoplasms|82389800|0-19|All Races|Male and Female|2006|28.8|31.2|30.0
2.4|3.2|2.8|231|III(a) Ependymomas and choroid plexus tumor|82389800|0-19|All Races|Male and Female|2006|2.5|3.2|2.8
13.9|15.6|14.7|1213|III(b) Astrocytomas|82389800|0-19|All Races|Male and Female|2006|13.9|15.6|14.7
5.7|6.7|6.2|512|III(c) Intracranial and intraspinal embryonal tumors|82389800|0-19|All Races|Male and Female|2006|5.7|6.8|6.2
4.6|5.6|5.1|418|III(d) Other gliomas|82389800|0-19|All Races|Male and Female|2006|4.6|5.6|5.1
0.4|0.7|0.6|46|III(e) Other specified intracranial & intraspinal neoplasms|82389800|0-19|All Races|Male and Female|2006|0.4|0.7|0.6
0.5|0.8|0.6|51|III(f) Unspecified intracranial and intraspinal neoplasms|82389800|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.0|8.2|7.5|639|IV Neuroblastoma and other peripheral nervous cell tumors|82389800|0-19|All Races|Male and Female|2006|7.2|8.4|7.8
6.8|8.0|7.4|627|IV(a) Neuroblastoma and ganglioneuroblastoma|82389800|0-19|All Races|Male and Female|2006|7.0|8.2|7.6
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82389800|0-19|All Races|Male and Female|2006|~|~|~
10.8|12.3|11.5|956|IX Soft tissue and other extraosseous sarcomas|82389800|0-19|All Races|Male and Female|2006|10.9|12.4|11.6
4.1|5.0|4.5|372|IX(a) Rhabdomyosarcomas|82389800|0-19|All Races|Male and Female|2006|4.1|5.0|4.5
1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82389800|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82389800|0-19|All Races|Male and Female|2006|~|~|~
4.0|4.9|4.5|370|IX(d) Other specified soft tissue sarcomas|82389800|0-19|All Races|Male and Female|2006|4.0|5.0|4.5
1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|82389800|0-19|All Races|Male and Female|2006|1.0|1.5|1.2
0.2|0.5|0.3|26|Not classified by ICCC|82389800|0-19|All Races|Male and Female|2006|0.2|0.5|0.3
2.6|3.3|2.9|249|V Retinoblastoma|82389800|0-19|All Races|Male and Female|2006|2.7|3.4|3.0
6.0|7.1|6.5|546|VI Renal tumors|82389800|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
5.3|6.3|5.8|486|VI(a) Nephroblastoma and other nonepithelial renal tumors|82389800|0-19|All Races|Male and Female|2006|5.4|6.4|5.9
0.5|0.8|0.6|54|VI(b) Renal carcinomas|82389800|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82389800|0-19|All Races|Male and Female|2006|~|~|~
1.9|2.6|2.2|190|VII Hepatic tumors|82389800|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.3|1.9|1.6|135|VII(a) Hepatoblastoma|82389800|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
0.4|0.8|0.6|50|VII(b) Hepatic carcinomas|82389800|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82389800|0-19|All Races|Male and Female|2006|~|~|~
8.7|10.0|9.3|767|VIII Malignant bone tumors|82389800|0-19|All Races|Male and Female|2006|8.7|10.0|9.3
4.9|6.0|5.4|448|VIII(a) Osteosarcomas|82389800|0-19|All Races|Male and Female|2006|4.9|6.0|5.4
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82389800|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.6|3.4|3.0|246|VIII(c) Ewing tumor and related sarcomas of bone|82389800|0-19|All Races|Male and Female|2006|2.6|3.4|3.0
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|82389800|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82389800|0-19|All Races|Male and Female|2006|~|~|~
9.5|10.8|10.1|851|X Germ cell, trophoblastic tumors & neoplasms of gonads|82389800|0-19|All Races|Male and Female|2006|9.6|11.0|10.3
1.2|1.8|1.5|122|X(a) Intracranial & intraspinal germ cell tumors|82389800|0-19|All Races|Male and Female|2006|1.2|1.8|1.5
1.2|1.7|1.5|124|X(b) Malignant extracranial & extragonadal germ cell tumors|82389800|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
5.9|6.9|6.4|537|X(c) Malignant gonadal germ cell tumors|82389800|0-19|All Races|Male and Female|2006|6.0|7.1|6.5
0.3|0.7|0.5|41|X(d) Gonadal carcinomas|82389800|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|82389800|0-19|All Races|Male and Female|2006|0.2|0.5|0.3
16.5|18.3|17.4|1452|XI Other malignant epithelial neoplasms and malignant melanomas|82389800|0-19|All Races|Male and Female|2006|16.7|18.6|17.6
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82389800|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.2|7.3|6.7|562|XI(b) Thyroid carcinomas|82389800|0-19|All Races|Male and Female|2006|6.3|7.4|6.8
0.5|0.8|0.6|53|XI(c) Nasopharyngeal carcinomas|82389800|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
5.1|6.1|5.5|464|XI(d) Malignant melanomas|82389800|0-19|All Races|Male and Female|2006|5.1|6.2|5.6
~|~|~|~|XI(e) Skin carcinomas|82389800|0-19|All Races|Male and Female|2006|~|~|~
3.8|4.7|4.2|352|XI(f) Other and unspecified carcinomas|82389800|0-19|All Races|Male and Female|2006|3.8|4.7|4.3
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|82389800|0-19|All Races|Male and Female|2006|0.7|1.2|0.9
0.3|0.7|0.5|41|XII(a) Other specified malignant tumors|82389800|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.6|0.4|35|XII(b) Other unspecified malignant tumors|82389800|0-19|All Races|Male and Female|2006|0.3|0.6|0.4
169.5|175.1|172.3|14435|All ICCC Groups Combined|82856970|0-19|All Races|Male and Female|2007|171.4|177.1|174.2
44.2|47.1|45.7|3820|I Leukemias, myeloproliferative & myelodysplastic diseases|82856970|0-19|All Races|Male and Female|2007|44.7|47.6|46.1
31.7|34.2|33.0|2753|I(a) Lymphoid leukemias|82856970|0-19|All Races|Male and Female|2007|32.0|34.5|33.2
7.2|8.5|7.8|655|I(b) Acute myeloid leukemias|82856970|0-19|All Races|Male and Female|2007|7.3|8.5|7.9
2.0|2.7|2.3|195|I(c) Chronic myeloproliferative diseases|82856970|0-19|All Races|Male and Female|2007|2.0|2.7|2.4
1.1|1.7|1.4|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82856970|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
1.0|1.4|1.2|100|I(e) Unspecified and other specified leukemias|82856970|0-19|All Races|Male and Female|2007|1.0|1.5|1.2
23.9|26.0|24.9|2078|II Lymphomas and reticuloendothelial neoplasms|82856970|0-19|All Races|Male and Female|2007|24.0|26.2|25.1
11.5|13.0|12.2|1022|II(a) Hodgkin lymphomas|82856970|0-19|All Races|Male and Female|2007|11.6|13.1|12.3
8.1|9.4|8.7|720|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82856970|0-19|All Races|Male and Female|2007|8.1|9.3|8.7
2.3|3.0|2.6|214|II(c) Burkitt lymphoma|82856970|0-19|All Races|Male and Female|2007|2.2|3.0|2.6
0.8|1.2|1.0|85|II(d) Miscellaneous lymphoreticular neoplasms|82856970|0-19|All Races|Male and Female|2007|0.8|1.3|1.0
0.3|0.6|0.4|37|II(e) Unspecified lymphomas|82856970|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
29.3|31.7|30.5|2531|III CNS and misc intracranial and intraspinal neoplasms|82856970|0-19|All Races|Male and Female|2007|29.4|31.8|30.5
2.1|2.8|2.4|202|III(a) Ependymomas and choroid plexus tumor|82856970|0-19|All Races|Male and Female|2007|2.1|2.8|2.4
14.2|15.9|15.0|1244|III(b) Astrocytomas|82856970|0-19|All Races|Male and Female|2007|14.2|15.9|15.0
5.8|6.9|6.4|530|III(c) Intracranial and intraspinal embryonal tumors|82856970|0-19|All Races|Male and Female|2007|5.9|7.0|6.4
5.0|6.0|5.5|454|III(d) Other gliomas|82856970|0-19|All Races|Male and Female|2007|5.0|6.0|5.5
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|82856970|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|82856970|0-19|All Races|Male and Female|2007|0.4|0.7|0.5
7.9|9.1|8.5|733|IV Neuroblastoma and other peripheral nervous cell tumors|82856970|0-19|All Races|Male and Female|2007|8.2|9.5|8.8
7.7|8.9|8.3|717|IV(a) Neuroblastoma and ganglioneuroblastoma|82856970|0-19|All Races|Male and Female|2007|8.0|9.3|8.7
0.1|0.3|0.2|16|IV(b) Other peripheral nervous cell tumors|82856970|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
11.5|13.0|12.2|1023|IX Soft tissue and other extraosseous sarcomas|82856970|0-19|All Races|Male and Female|2007|11.6|13.1|12.3
4.6|5.6|5.1|422|IX(a) Rhabdomyosarcomas|82856970|0-19|All Races|Male and Female|2007|4.6|5.6|5.1
1.1|1.6|1.3|110|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82856970|0-19|All Races|Male and Female|2007|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82856970|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.2|4.7|394|IX(d) Other specified soft tissue sarcomas|82856970|0-19|All Races|Male and Female|2007|4.3|5.2|4.8
0.9|1.4|1.1|94|IX(e) Unspecified soft tissue sarcomas|82856970|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
0.2|0.4|0.3|23|Not classified by ICCC|82856970|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
2.6|3.4|3.0|259|V Retinoblastoma|82856970|0-19|All Races|Male and Female|2007|2.8|3.5|3.1
6.2|7.3|6.7|566|VI Renal tumors|82856970|0-19|All Races|Male and Female|2007|6.3|7.4|6.8
5.5|6.5|6.0|509|VI(a) Nephroblastoma and other nonepithelial renal tumors|82856970|0-19|All Races|Male and Female|2007|5.6|6.7|6.1
0.5|0.9|0.7|55|VI(b) Renal carcinomas|82856970|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82856970|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.6|2.3|194|VII Hepatic tumors|82856970|0-19|All Races|Male and Female|2007|2.0|2.7|2.3
1.4|1.9|1.6|142|VII(a) Hepatoblastoma|82856970|0-19|All Races|Male and Female|2007|1.4|2.0|1.7
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82856970|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82856970|0-19|All Races|Male and Female|2007|~|~|~
8.0|9.3|8.7|714|VIII Malignant bone tumors|82856970|0-19|All Races|Male and Female|2007|8.0|9.3|8.6
4.2|5.2|4.7|386|VIII(a) Osteosarcomas|82856970|0-19|All Races|Male and Female|2007|4.2|5.1|4.7
0.2|0.5|0.3|29|VIII(b) Chondrosarcomas|82856970|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
2.7|3.4|3.0|251|VIII(c) Ewing tumor and related sarcomas of bone|82856970|0-19|All Races|Male and Female|2007|2.7|3.4|3.0
0.2|0.5|0.3|26|VIII(d) Other specified malignant bone tumors|82856970|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|82856970|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.4|11.8|11.1|938|X Germ cell, trophoblastic tumors & neoplasms of gonads|82856970|0-19|All Races|Male and Female|2007|10.6|12.1|11.3
1.4|1.9|1.6|135|X(a) Intracranial & intraspinal germ cell tumors|82856970|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.6|1.3|116|X(b) Malignant extracranial & extragonadal germ cell tumors|82856970|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
6.9|8.1|7.5|637|X(c) Malignant gonadal germ cell tumors|82856970|0-19|All Races|Male and Female|2007|7.1|8.3|7.7
0.2|0.5|0.4|30|X(d) Gonadal carcinomas|82856970|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.1|0.4|0.2|20|X(e) Other and unspecified malignant gonadal tumors|82856970|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
16.8|18.6|17.7|1494|XI Other malignant epithelial neoplasms and malignant melanomas|82856970|0-19|All Races|Male and Female|2007|17.1|19.0|18.0
~|~|~|~|XI(a) Adrenocortical carcinomas|82856970|0-19|All Races|Male and Female|2007|~|~|~
6.7|7.9|7.3|613|XI(b) Thyroid carcinomas|82856970|0-19|All Races|Male and Female|2007|6.8|8.0|7.4
0.5|0.8|0.6|53|XI(c) Nasopharyngeal carcinomas|82856970|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
4.9|5.9|5.4|458|XI(d) Malignant melanomas|82856970|0-19|All Races|Male and Female|2007|5.0|6.1|5.5
~|~|~|~|XI(e) Skin carcinomas|82856970|0-19|All Races|Male and Female|2007|~|~|~
3.7|4.6|4.1|346|XI(f) Other and unspecified carcinomas|82856970|0-19|All Races|Male and Female|2007|3.7|4.6|4.2
0.6|0.9|0.7|62|XII Other and unspecified malignant neoplasms|82856970|0-19|All Races|Male and Female|2007|0.6|1.0|0.7
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|82856970|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
0.3|0.6|0.4|34|XII(b) Other unspecified malignant tumors|82856970|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
167.7|173.3|170.4|14346|All ICCC Groups Combined|83197604|0-19|All Races|Male and Female|2008|169.6|175.3|172.4
44.5|47.4|45.9|3865|I Leukemias, myeloproliferative & myelodysplastic diseases|83197604|0-19|All Races|Male and Female|2008|45.0|47.9|46.5
31.7|34.1|32.9|2764|I(a) Lymphoid leukemias|83197604|0-19|All Races|Male and Female|2008|32.0|34.5|33.2
7.4|8.6|8.0|673|I(b) Acute myeloid leukemias|83197604|0-19|All Races|Male and Female|2008|7.5|8.7|8.1
2.1|2.8|2.5|207|I(c) Chronic myeloproliferative diseases|83197604|0-19|All Races|Male and Female|2008|2.2|2.9|2.5
1.2|1.7|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83197604|0-19|All Races|Male and Female|2008|1.2|1.8|1.5
0.9|1.4|1.2|98|I(e) Unspecified and other specified leukemias|83197604|0-19|All Races|Male and Female|2008|1.0|1.4|1.2
24.0|26.2|25.1|2096|II Lymphomas and reticuloendothelial neoplasms|83197604|0-19|All Races|Male and Female|2008|24.1|26.3|25.2
12.1|13.7|12.9|1079|II(a) Hodgkin lymphomas|83197604|0-19|All Races|Male and Female|2008|12.2|13.8|13.0
7.9|9.2|8.6|714|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83197604|0-19|All Races|Male and Female|2008|8.0|9.2|8.6
2.2|2.9|2.5|207|II(c) Burkitt lymphoma|83197604|0-19|All Races|Male and Female|2008|2.2|2.9|2.5
0.6|1.0|0.8|70|II(d) Miscellaneous lymphoreticular neoplasms|83197604|0-19|All Races|Male and Female|2008|0.7|1.1|0.8
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83197604|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
28.6|30.9|29.7|2481|III CNS and misc intracranial and intraspinal neoplasms|83197604|0-19|All Races|Male and Female|2008|28.7|31.0|29.8
1.9|2.6|2.2|187|III(a) Ependymomas and choroid plexus tumor|83197604|0-19|All Races|Male and Female|2008|1.9|2.6|2.2
14.0|15.6|14.8|1230|III(b) Astrocytomas|83197604|0-19|All Races|Male and Female|2008|14.0|15.6|14.8
5.9|7.0|6.4|538|III(c) Intracranial and intraspinal embryonal tumors|83197604|0-19|All Races|Male and Female|2008|5.9|7.0|6.5
4.7|5.7|5.2|431|III(d) Other gliomas|83197604|0-19|All Races|Male and Female|2008|4.7|5.7|5.2
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|83197604|0-19|All Races|Male and Female|2008|0.5|0.9|0.7
0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|83197604|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
7.1|8.2|7.6|662|IV Neuroblastoma and other peripheral nervous cell tumors|83197604|0-19|All Races|Male and Female|2008|7.4|8.6|8.0
6.9|8.0|7.4|644|IV(a) Neuroblastoma and ganglioneuroblastoma|83197604|0-19|All Races|Male and Female|2008|7.2|8.4|7.7
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|83197604|0-19|All Races|Male and Female|2008|0.1|0.3|0.2
11.1|12.6|11.8|992|IX Soft tissue and other extraosseous sarcomas|83197604|0-19|All Races|Male and Female|2008|11.2|12.7|11.9
4.4|5.4|4.9|410|IX(a) Rhabdomyosarcomas|83197604|0-19|All Races|Male and Female|2008|4.5|5.4|4.9
0.8|1.2|1.0|84|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83197604|0-19|All Races|Male and Female|2008|0.8|1.3|1.0
~|~|~|~|IX(c) Kaposi sarcoma|83197604|0-19|All Races|Male and Female|2008|~|~|~
4.1|5.0|4.5|376|IX(d) Other specified soft tissue sarcomas|83197604|0-19|All Races|Male and Female|2008|4.1|5.0|4.5
1.2|1.7|1.4|121|IX(e) Unspecified soft tissue sarcomas|83197604|0-19|All Races|Male and Female|2008|1.2|1.7|1.5
0.2|0.4|0.3|24|Not classified by ICCC|83197604|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
2.6|3.3|2.9|256|V Retinoblastoma|83197604|0-19|All Races|Male and Female|2008|2.7|3.5|3.1
6.2|7.4|6.8|581|VI Renal tumors|83197604|0-19|All Races|Male and Female|2008|6.4|7.6|7.0
5.5|6.5|6.0|516|VI(a) Nephroblastoma and other nonepithelial renal tumors|83197604|0-19|All Races|Male and Female|2008|5.7|6.8|6.2
0.6|0.9|0.7|62|VI(b) Renal carcinomas|83197604|0-19|All Races|Male and Female|2008|0.6|1.0|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|83197604|0-19|All Races|Male and Female|2008|~|~|~
1.9|2.5|2.2|189|VII Hepatic tumors|83197604|0-19|All Races|Male and Female|2008|2.0|2.6|2.3
1.4|1.9|1.6|142|VII(a) Hepatoblastoma|83197604|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
0.4|0.7|0.6|46|VII(b) Hepatic carcinomas|83197604|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83197604|0-19|All Races|Male and Female|2008|~|~|~
8.0|9.3|8.6|709|VIII Malignant bone tumors|83197604|0-19|All Races|Male and Female|2008|7.9|9.2|8.5
4.4|5.4|4.9|401|VIII(a) Osteosarcomas|83197604|0-19|All Races|Male and Female|2008|4.4|5.3|4.8
0.3|0.6|0.4|35|VIII(b) Chondrosarcomas|83197604|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
2.4|3.1|2.7|225|VIII(c) Ewing tumor and related sarcomas of bone|83197604|0-19|All Races|Male and Female|2008|2.4|3.1|2.7
0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|83197604|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
0.1|0.4|0.2|20|VIII(e) Unspecified malignant bone tumors|83197604|0-19|All Races|Male and Female|2008|0.1|0.4|0.2
10.2|11.6|10.9|926|X Germ cell, trophoblastic tumors & neoplasms of gonads|83197604|0-19|All Races|Male and Female|2008|10.4|11.9|11.1
1.4|2.0|1.7|141|X(a) Intracranial & intraspinal germ cell tumors|83197604|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
1.1|1.7|1.4|120|X(b) Malignant extracranial & extragonadal germ cell tumors|83197604|0-19|All Races|Male and Female|2008|1.2|1.7|1.4
6.8|7.9|7.3|623|X(c) Malignant gonadal germ cell tumors|83197604|0-19|All Races|Male and Female|2008|6.9|8.1|7.5
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83197604|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83197604|0-19|All Races|Male and Female|2008|~|~|~
17.0|18.8|17.8|1505|XI Other malignant epithelial neoplasms and malignant melanomas|83197604|0-19|All Races|Male and Female|2008|17.2|19.0|18.1
0.1|0.3|0.2|18|XI(a) Adrenocortical carcinomas|83197604|0-19|All Races|Male and Female|2008|0.1|0.3|0.2
7.3|8.5|7.9|667|XI(b) Thyroid carcinomas|83197604|0-19|All Races|Male and Female|2008|7.4|8.6|8.0
0.4|0.7|0.6|46|XI(c) Nasopharyngeal carcinomas|83197604|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
4.3|5.3|4.8|403|XI(d) Malignant melanomas|83197604|0-19|All Races|Male and Female|2008|4.4|5.3|4.8
~|~|~|~|XI(e) Skin carcinomas|83197604|0-19|All Races|Male and Female|2008|~|~|~
3.9|4.8|4.4|367|XI(f) Other and unspecified carcinomas|83197604|0-19|All Races|Male and Female|2008|4.0|4.9|4.4
0.5|0.9|0.7|60|XII Other and unspecified malignant neoplasms|83197604|0-19|All Races|Male and Female|2008|0.6|0.9|0.7
0.2|0.5|0.3|30|XII(a) Other specified malignant tumors|83197604|0-19|All Races|Male and Female|2008|0.2|0.5|0.4
0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|83197604|0-19|All Races|Male and Female|2008|0.2|0.5|0.4
